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VASCULAR KATP CHANNEL MODULATION BY S-GLUTATHIONYLATION: A
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YANG YANG
Under the Direction of Dr. Chun Jiang

ABSTRACT
The KATP channels play an important role in the membrane excitability and vascular tone
regulation. Previous studies indicate that the function of KATP channels is disrupted in oxidative
stress seen in a variety of cardiovascular diseases, while the underlying mechanism remains
unclear. Here, we demonstrate S-glutathionylation to be a modulation mechanism underlying the
oxidant-mediated vascular KATP channel inhibition, the molecular basis for the channel inhibition
and the alleviation of the channel inhibition by vasoactive intestinal peptide (VIP). We found
that an exposure of isolated mesenteric rings to H2O2 impaired the KATP channel-mediated
vascular dilation. In whole-cell recordings and inside-out patches, micromolar H2O2 or diamide
caused a strong inhibition of the vascular KATP channel (Kir6.1/SUR2B) in the presence, but not
in the absence, of glutathione (GSH), indicating S-glutathionylation. By co-expressions of Kir6.1
or Kir6.2 with SUR2B subunits, we found that the oxidant sensitivity of the K ATP channel relied
on the Kir6.1 subunit. Systematic mutational analysis revealed three cysteine residues (Cys43,
Cys120 and Cys176) to be important. Among them, Cys176 was prominent, contributing to
>80% oxidant sensitivity. Biochemical pull-down assay with biotinylated glutathione ethyl ester
(BioGEE) showed that mutations of Cys176 impaired the oxidant-induced incorporation of GSH

to the Kir6.1 subunit. Simulation modeling of Kir6.1 S-glutathionylation revealed that after
incorporation to residue 176, the GSH moiety occupied a space between slide helix and two
transmembrane helices. This prevented the necessary conformational change of the inner helix
for channel gating, and retained the channel in its closed state. VIP is a potent vasodilator, and is
shown to have protective role against oxidative stress. We found that the channel was strongly
augmented by VIP and the channel activation relied on PKA phosphorylation. These results
therefore indicate that 1) the vascular KATP channel is strongly inhibited in oxidative stress, 2) Sglutathionylation underlies the oxidant-mediated KATP channel inhibition, 3) Cys176 in the
Kir6.1 subunit is the major site for S-glutathionylation, and 4) the Kir6.1/SUR2B channel is
activated in a PKA-dependent manner by VIP that has been previously shown to alleviate
oxidative stress.

INDEX WORDS: Kir6.1, SUR2B, ATP-sensitive K+ channels, KATP channel, Vascular tone,
Oxidative stress, S-glutathionylation, Structural modeling, Protein kinase A, Vasodilators,
Vasoconstrictors, Vasoactive intestinal peptide, Reactive oxygen species.
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1. SPECIFIC AIMS AND HYPOTHESES
Several reactive species are produced under pathological and pathophysiological
conditions, such as reactive oxygen species (ROS) and reactive carbonyl species (RCS).
Oxidative stress takes place when the production of these reactive species becomes long-lasting
and exceeds the cellular anti-oxidant defense systems, which is seen in inflammation, diabetes,
cardiovascular disease, neurodegenerative disorders, etc. The reactive species can modify
proteins, lipids and DNAs, causing cellular dysfunction and structural damages. In vasculatures,
the reactive species, especially ROS, can be released from damaged tissues, neutrophils,
macrophages, and vascular endothelium. Plasma membranes and membrane proteins of the
endothelial cells and smooth muscle cells (SMCs) are the primary targets of ROS. Some of these
membrane proteins are critical for membrane potential regulation. Dysfunctions of these proteins
can result in depolarization (Liu and Gutterman, 2002a; Oelze et al., 2006). Prolonged
depolarization triggers Ca++ influx through the voltage-gated Ca++ channels, and facilitates the
Ca++ release from intracellular Ca++ store in SMCs (Anzai et al., 2000; Wray et al., 2005). The
elevated cytosolic Ca++ further causes blood vessel contraction resulting in vascular dysfunction
and activation of other downstream effectors, including NADPH oxidase (NOX), some of which
are known to be sensitive to Ca++ and PKC (Brandes et al., 2010; Guzik et al., 2008; Hink et al.,
2001; Wendt et al., 2005; Zhang et al., 2008). Consequently, a cascade of events is initiated
leading to further depolarization and more ROS production (al-Mehdi et al., 1997; Lyle and
Griendling, 2006).
In SMCs, the membrane potential is primarily regulated by the ATP-sensitive K+ (KATP)
channel (Quayle et al., 1997; Teramoto, 2006), while the KATP channel is regulated by several
metabolites, vasodilators and vasoconstrictors. The activation of this channel lowers the
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membrane excitability, reduces the Ca++ influx, and may protect the cells from oxidative stress
(Quayle et al., 1997). Therefore, information about the KATP channel activity during oxidative
stress is critically important in the understanding of vascular responses to oxidative stress, which
however remains unknown. A number of questions remain open: For example, is the vascular
KATP channel a target of oxidative stress? How does the reactive species modulate K ATP channel
activity? What is the molecular mechanism underlying the modification? Does this modification
lead to vascular dysfunction? What protein domains and specific amino acid residues of KATP are
responsible for this modification? How does the activation of the KATP channel reduce the
membrane excitability and protect the cells against oxidative stress? Can the channel be activated
by endogenous vasodilators that play a protective role in oxidative stress? To address some of
these questions, a series of experiments is proposed with the objective to understand the
molecular and cellular basis for the modulation of the vascular KATP channel in oxidative stress.
The specific aim of this dissertation thus was to demonstrate whether and how the KATP channels
are modulated in oxidative stress. Three specific hypotheses were tested:
1.

The vascular KATP channel is a target of ROS and other oxidants via the protein

post-translational modification mechanism.
2.

This post-translational modification mechanism occurs on the cysteine residues

located in the critical domains of the vascular KATP channel and structurally affects the
channel gating.
3.

VIP, a peptide hormone that has protective role against oxidative stress, affects the

activity of vascular KATP channels via a specific intracellular signaling pathway.

19

2 GENERAL INTRODUCTION
2.1 Vascular tone regulation
2.1.1 Overview
Vascular tone in the mammalian system is dynamically regulated by neuronal, hormonal
and local metabolic mechanisms that are targeted at the heart and vasculatures. Disruption of this
regulation leads to cellular dysfunction and even severe diseases including ischemia, hyperemia,
shock and hypertension (Gutterman et al., 2005; Webb, 2003). Blood vessels are made of
endothelial cells and smooth muscle cells (SMCs). The endothelial cells form the blood vessel
lumen, while the SMCs wrap the endothelial cells and generate force to constrict or dilate the
blood vessels. Acting on either the vascular endothelium, smooth muscle or both, the regulation
of vascular tone is achieved by a complicated signaling network involving circulating hormones,
neurotransmitters and metabolites (Liu and Gutterman, 2009). The regulation of vascular tone is
often altered under pathological conditions. For example, hypertension may occur when the
SMCs cannot relax in response to vasodilators. In sepsis, the resistant arteries are dilated so
vastly that the blood pressure cannot be maintained by common vasoconstrictors. In addition, the
dysfunction of blood vessels can also be seen in diabetes, known to be the major cause of death
as a result of the development of diabetic vascular complications. The understanding of vascular
tone regulation therefore has a major impact on the treatment for these diseases.
2.1.2 Control of the vascular tone by membrane excitability
Vascular SMCs are excitable cells. Their membrane potentials are critical in determining
the smooth muscle contractility (Wray et al., 2005). Membrane depolarization mediated by the
closure of K+ channels leads to the activation of voltage-dependent Ca++ channels (VDCC). The
20

Ca++ influx through these VDCC raises the intracellular Ca++ concentration. The Ca++-induced
Ca++ release is then activated. A rise in intracellular Ca++ thus allows them to bind to calmodulin,
forming a Ca++-calmodulin complex. This complex further binds to myosin light-chain kinase
(MLCK) and activates it. Activated MLCK thus phosphorylates the myosin light-chain (Herring
et al., 2006), leading to the enhanced interaction of myosin with actin filaments, and smooth
muscle contraction. (Bolton, 2005; Webb, 2003; Wray et al., 2005).
On the other hand, hyperpolarization reduces the activity of the VDCC, lowers the
intracellular Ca++ levels, and eventually results in the relaxation of vascular SMCs. Since the
myosin phosphorylation is a critical step mediating the vasoconstriction, an increase in the
myosin light-chain phosphatase activity, that dephosphorylates the myosin light-chain is also an
important mechanism to cause the relaxation of vascular SMCs cells (Guibert et al., 2008; Wray
et al., 2005).
2.2 Kir channel superfamily
2.2.1 Kir channel overview
K+ channels play an important role in membrane potential regulations in virtually all
cells. In excitable cells, the membrane excitability is regulated specifically by K+ channels. K+
channels are grouped into 4 super-families: voltage-gated (KV) channels, Ca++ -activated K+
(KCa) channels, two-pore domain K+ (TASK) channels and inward rectifier K+ (Kir) channels.
KV channels are mainly expressed in excitable cells, contributing to the action potential
repolarization and shaping the frequency of action potentials. KCa channels consist of largeconductance (BK) channels and small-conductance (SK) channels, both of which are regulated
by the intracellular Ca++. TASK K+ channels are also known as ―leak K+ channels‖, mainly
contribute to the maintaining the resting membrane potential of the cells. Kir channels were
21

named by the special feature of this group of channels: K+ move through these channels into the
cells more easily than going out of the cells. They are divided into 7 subfamilies (Kir1.1 to
Kir7.1) (Hibino et al., 2010). Some suggest that they belong to 4 distinct groups (Hibino et al.,
2010). The first group is the classical Kir channels (Kir2.x), which is considered as constantly
activated Kir channels. The second group is the G protein-coupled Kir (GIRK) channels, also
known as Kir3.x channels. This group of Kir channels can be directly regulated by Gβγ proteins.
The third group is called the ATP-sensitive K+ channel (Kir6.x), activity of which, in general, is
associated with the cellular metabolic status. The Kir 6.x subunits do not form functional
channels by themselves. A special regulatory subunit i.e., the sulfonylurea receptor (SUR), is
required for the surface expression of the channels and their functional activity. Because of this
feature, these channels are often listed as a distinct channel family rather than a group of Kir
channels. The last group of Kir channels is referred to as K+ transport channels. This is the
biggest group in the Kir family, which includes Kir1x, Kir4x, Kir5.1 and Kir7.1 (Bichet et al.,
2003; Hibino et al., 2010).
2.2.2 Kir channel structure
Several crystal structures of Kir channels have been resolved, including bacterial
KirBac1.1 and the recent chicken Kir2.2 (Kuo et al., 2005; Kuo et al., 2003; Tao et al., 2009). It
is clear that the core structure of Kir channel is conserved, sharing a high similarity with other K+
channels including KcsA, MthK and KV channels. The core domain of Kir channels comprises of
1) two transmembrane helices named outer helix (TM1) and inner helix (TM2), 2) the pore loop
or selectivity filters, and 3) the slide helix. The slide helix is distinct in the Kir channels, and
does not exist in other K+ channels. The selectivity filter is highly conserved among K+ channels,
with a signature sequence of T-XG-Y(F)-G (T, threonine; X, any amino acid, G, glycine; Y,
22

tyrosine; F, phenylalanine). Because the Kir channels are not voltage sensitive, they do not have
other transmembrane domains e.g., the S1-S4 voltage paddle. The C- and N-termini form
intracellular domains which vary among different Kir channels.
Several residues of the transmembrane helices have been pointed out in the structure of
Kir channel to play central roles in the channel gating (Kuo et al., 2005; Kuo et al., 2003; Tao et
al., 2009). One key residue in the TM2 is phenylalanine (Phe146 in KirBac1.1), which is located
in the narrowest neck of the ion conductance pathway. When the channel enters the closed state,
the bulk residue blocks the ion conductance pathway and prevents the ions from passing through.
A glycine residue (Gly83 in KirBac1.1) is critical, that is known to form a flexible point in αhelix. When the channel enters its open state, the TM2 helix bends at the glycine residue, moving
the side-chain of the blocking Phe146 away from the center. This movement allows the ions to
pass through the channel. A cysteine residue (Cys166 in Kir6.2) is known to play an important
role in Kir6.2 channel gating. The concentration of the residues critical for Kir channel gating at
a narrow region of TM2 suggests that other channel regulation mechanisms may be also located
in the inner mouth of the ion-conductive pathway. Taking the advantage of the bacterial and
chicken Kir channel crystal structures, we modeled our Kir6.1 subunit of the KATP channel to
study the effect of S-glutathionylation on the gating of the KATP channels.
2.2.3 Inwardly rectifying feature
The Kir channels feature the ability to let more K+ ions enter the cell than leaving from
the cell. Two intracellular substances (Mg++, and polyamines) determine the inward rectification,
which interact with the lining of the channel pore, physically block the channel pore
intracellularly. Such a blockage relies specifically on a negatively charged residue (Asp172 of
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the strong rectifier Kir2.1 channel) in the TM2 helix (Ficker et al., 1994; Wible et al., 1994),
which is also critical for pH sensitivity and the unitary conductance in Kir4.1 (Xu et al., 2000) .
Among the Kir channel superfamily, different Kir channels show varying levels of inward
rectification. Kir2.x and Kir3.x are considered as strong rectifiers, Kir4.x as intermediate, while
Kir1.x and Kir6.x as weak rectifiers. Consistently, Asp at TM2 helix is found in the strong
rectifiers and this residue is replaced by an uncharged Asparagine (Asn) in weak rectifiers. Sitedirected mutagenesis has shown that if the Asp in Kir1.1 is changed to Asn experimentally, the
weak rectifier Kir1.1 becomes a strong rectifier, showing an increase in binding affinity for Mg++
(Ficker et al., 1994; Wible et al., 1994). The channels studied in my dissertation were Kir6.x
(Kir6.1 and Kir6.2) channels, which have weak inward rectification.
2.2.4 Kir channel blockers.
Specific Kir channel blockers are not available. However, Ba++ is often used in research
as a relatively specific blocker for Kir channels. The specificity is dependent on the
concentration of these ions. Micromolar concentration of Ba++ is able to block Kir channel but
not other channels, whereas higher concentration can also affect KV channels. In contrast, the KV
channel inhibitor tetraethylammonium (TEA) and 4-aminopyridine (4-AP) have very little
effects on Kir channels (Hibino et al., 2010; Oliver et al., 1998).
2.3 ATP-sensitive K+ or KATP channels
2.3.1 Discovery of KATP channel
The KATP channel activity was first recorded in cardiac muscles (Noma, 1983). Later, the
KATP currents were also identified in other tissues including: pancreatic β-cells (Ashcroft et al.,
1984; Cook and Hales, 1984), skeletal muscle (Spruce et al., 1987), vascular SMCs (Standen et
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al., 1989), and neurons (Ashford et al., 1988). Most KATP channels are sensitive to the
intracellular ATP/ADP ratio. They are inhibited by ATP and activated by NDP e.g., MgADP.
The vascular isoform of KATP channel is activated by intracellular NDP but has very little
sensitivity to ATP. By sensing the ATP and NDP levels, these KATP channels are able to couple
the cellular metabolism to membrane excitability.
The successful cloning of KATP channel was not achieved until 1995 (Inagaki et al.,
1995). Initially, the Kir subunit was cloned from rat pancreatic islets but this clone did not show
any functional current. Only after the cloning of the SUR subunit (Aguilar-Bryan et al., 1995),
the functional KATP currents were recorded in the expression system.
2.3.2 SUR regulatory subunit
The SUR belongs to the ―C‖ branch of the ATP binding cassette (ABC) protein
superfamily, which also includes multidrug resistance proteins (MRPs) and cystic fibrosis
conductance regulator (CFTR/ABCC7). Typical ABC transporters have two clusters of
membrane spanning domains (MSDs), each containing 6 transmembrane helices and 2
nucleotide binding (NBD) domains, with high-affinity ATP binding motifs. The NBDs are
located intracellularly and link adjacent MSDs (Matsuo et al., 2000).
The SURs are considered as ―long‖ ABCC proteins, with three MSDs and two NBDs.
Each MSD1 and MSD2 is made of 6 transmembrane helices while MSD0 has five
transmembrane helices. Therefore, SUR is a big transmembrane protein with 17 membrane
spanning domains and an N-terminus located on the extracellular side.
The two NBDs in the SUR subunit can bind and hydrolyze ATP. The hydrolysis of ATP
by NDB generates energy towards the conformational change of the MSD domains, which may
further produce a force for the gating the pore forming Kir subunit. The catalytic sites of NBDs
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are made up of Walker-A-motif of one NBD domain and the ABC signature sequence motif (Cmotif) of the other NBD. Besides, several other conservative motifs exists in the NBD1 and
NBD2, including Q-Loop, D-loop and H-loop (Deeley et al., 2006).
Without the major domains, the TMD0 domain of the SUR subunit itself could greatly
enhance the C-terminus truncated form of Kir6.2 channels activity. The combination of TMD0
and Kir6.2 thus is known as ―mini-KATP channel‖ (Babenko and Bryan, 2002, 2003; Chan et al.,
2003). The mini-KATP channel cannot be regulated by sulfonylureas, Mg++-NDP or channel
openers but it retains the ATP sensitivity. These data suggest that the ATP binding site is
probably located in the domains of mini-KATP channel, and a complete SUR subunit is necessary
for sulfonylurea, K+ channel opener (KCO) and NDP to have effect on the channel activity
(Babenko and Bryan, 2002, 2003).
The SUR has two isoforms (abcc8/SUR1 and abcc9/SUR2). The SUR2 mRNA can
undergo alternative splicing and generates SUR2A and SUR2B, which differ only at the last 42
amino acids in the C-terminus (C42). Interestingly, the C42 of SUR2B shares a pretty high
similarity with that of SUR1 (Isomoto et al., 1996).
The interactions of Kir and SUR subunits, which lead to KATP channel gating, are still
elusive. It is suggested that the TMD0 domain of the SUR subunit interacts with the sliding
helix, outer helix and N-terminus of Kir subunit (Babenko and Bryan, 2002, 2003). The adjacent
L0 linker may bridge the Kir6.2/MSD0 with the core SUR (Fang et al., 2006). Lately, an ED
domain of SUR2A, containing 15 negatively charged amino acid residues, has been identified
that acts as a transducer that links the conformational change of sulfonylurea receptor to gating
of Kir6.2 (Karger et al., 2008). When the SUR undergoes conformational change upon the
stimulation of channel opener, it generates a lateral tension force that pulls the slide helix. The
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lateral movement of the slide helix further causes the conformational change of the inner poreforming helix and moves the gate away to open the channel.
2.3.3 Tissue distribution and molecular identity
KATP channels have been identified in a number of tissues including pancreatic β cells,
SMCs, heart muscle cells, and neurons: Kir6.2/SUR1 isoform is expressed in the β cells, where
the closure of Kir6.2/SUR1 by an increase ATP/ADP ratio leads to the membrane depolarization
of β-cells and insulin secretion. Kir6.1/SUR2B isoform is mainly expressed in the SMCs,
contributing to the vascular tone regulation. The opening of Kir6.1/SUR2B channel
hyperpolarizes the membrane resulting in the closure of VDCCs and producing vasodilation.
Heart muscle cells mainly contain the Kir6.2/SUR2A isoform, which is suggested to be involved
in cardioprotection in ischemic conditions. During ischemia, the opening of cardiac KATP
channels shortens the action potential duration and limits the harmful Ca++ influx (Nichols and
Lederer, 1991; Nichols et al., 1991; Noma, 1983). The molecular identities of KATP channels in
the neurons are less known. KATP channels have been found in ―glucose sensitive neurons‖ of
hypothalamus and in pro-opiomelanocortin (POMC) neurons. Like in the β cells, the elevated
ATP closes the KATP channel, depolarizes the membranes, and increases the excitation of
neurons. Kir6.2 is suggested to be the major isoform of KATP channel in certain neurons (e.g., rat
dorsal vagal neurons, hypothalamus neurons) (Karschin et al., 1998; Miki et al., 2001) while
Kir6.1 and SUR1 have been detected in another study on glucose-receptive neurons of rat
ventromedial hypothalamus (Lee et al., 1999). The opening of neuronal KATP channel may
protect neurons under pathological conditions like ischemia and hypoxia by suppressing the
neuronal activity (Soundarapandian et al., 2007b). The detailed mechanisms underlying the
inhibition of the neural activity by glucose through KATP channel are still under investigation.
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Besides the plasma membrane expression, KATP channels are also found in the mitochondria.
Surprisingly, the molecular identity of these KATP channel is still elusive and the channel
conductance is not consistent with any of the known KATP channels (Soundarapandian et al.,
2007b).
2.3.4 Biophysical properties of KATP channels
Physiological and pharmacological analysis has characterized distinct properties of K ATP
channels in different tissues. Native KATP channels display quite different unitary conductance,
for example, currents with ~70-90 pS were detected in cardiac muscle; ~55-75 pS in skeletal
muscle and ~50-90 pS in pancreatic β-cells. In vascular smooth muscle, although a large current
has been reported initially, the major evidence supports a channel conductance ~ 15-25 pS
(Kajioka et al., 1991; Kamouchi and Kitamura, 1994). NDP is indispensable for the activity of
this channel (Beech et al., 1993).
Cloned Kir6.2 containing channels have a conductance of 80 pS while in Kir6.1
containing channel, it is ~30 pS. Kir6.1/SUR2B channels resemble native vascular K ATP
channels, having a unitary conductance of ~35 pS and low basal activity in the absence of ATP
(Quayle et al., 1997; Yamada et al., 1997).
2.3.5 KATP channel opener and inhibitor
Unlike other Kir channels where there is no specific channel opener and blocker, K ATP
channel can be inhibited and activated rather specifically due to the presence of SUR subunit.
The KATP channel inhibitors and openers are classified into two groups of therapeutic compounds
known as sulfonylureas and KCOs, respectively (Hibino et al., 2010).
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Sulfonylureas include glibenclamide, tolbutamide, acetohexamide, etc. These drugs were
initially used to treat typhoid fever but were unexpectedly found to cause hypoglycemia, which
later was used to alleviate the hyperglycemia seen in diabetes. Currently these drugs are mainly
used for the treatment of type 2 diabetes because of their specific inhibitory effects on the KATP
channels of β-cells (Hibino et al., 2010). In this dissertation, we used glibenclamide as the
specific KATP channel inhibitor, because it is a reliable and potent inhibitor for KATP channel in a
variety of preparations.
The KCO is another group of drugs composing of pinacidil, diazoxide, nicorandil,
cromakalim, etc. They are used outside of USA to reduce blood pressure and control
hypertension. Nicorandil, one of the KCOs, is used for the treatment of angina pectoris in Japan.
Interestingly, different KATP channels respond to KCOs differently, which is attributed to the
different SUR isoforms. Research found that β-cell type KATP channels (with SUR1 isoform)
respond to diazoxide effectively and to pinacidil weakly. These channels are insensitive to
cromakalim or nicorandil. On the other hand, KATP channels expressed in cardiac muscle
(SUR2A isoform) are sensitive to pinacidil, cromakalim and nicorandil with little sensitivity to
diazoxide. The smooth muscle isoform of KATP channels are sensitive to all of these KCOs
because of the SUR2B isoform of the SUR subunit (Hibino et al., 2010). Among these KCO, we
chose to use pinacidil to activate the KATP channels to achieve large currents and to obtain better
experimental resolution.
2.3.6 The regulation of KATP channel by metabolites
Kir6.2 containing channels are highly sensitive to metabolic states especially the
ATP/ADP ratio. ATP in its free acid form is a strong channel inhibitor (Ashcroft and Kakei,
1989). Each Kir6.2 subunit has one ATP binding site so four ATP molecules can bind to a single
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KATP channel. However, the binding of one ATP is sufficient to cause channel closure
(Markworth et al., 2000). In the presence of Mg++, however, ATP maintains the channel activity
through

PtdIns(4,5)P2,

which

is

generated

by

ATP-dependent

lipid

kinase

from

phosphatidylinositol (Huang et al., 1998). NDPs including ADP are also essential for the channel
activity. They increase the channel activity independently of ATP. This activation effect of NDP
requires the presence of Mg++ and the binding site of NDP is located in the SUR subunit (Matsuo
et al., 2000). Therefore, a KATP channel has two distinct sites (a stimulatory NDP-binding site
and an inhibitory ATP-binding site) to sense the metabolic state.
The Kir6.1-containing channels, including the vascular Kir6.1/SUR2B channel, have low
open probability in physiological conditions and only respond to the ATP modestly. Therefore,
the Kir6.1-containing channels are often known as KNDP channels. Not only is the vascular KATP
channel regulation attributed to cellular metabolism directly, but also their activity relies largely
on other factors that are related to metabolic states. For example, low pH, which occurs during
the metabolic stress, has been shown to drastically activate vascular KATP channel (Santa et al.,
2003; Wang et al., 2003). In addition, these channels are targeted by a number of
neurotransmitter or circulating hormones (discussed in below).
Each Kir6.2 subunit has a binding site for one molecule of ATP, and the binding of one
ATP to one subunit is enough to cause channel closure. Therefore, in the physiological
conditions when ATP concentration is in millimolar range, the KATP channel is supposed to
remain closed. However, KATP channel activity recorded on native β-cells is significantly higher.
It is likely that KATP channel integrates the stimulatory inputs from MgADP, phospholipids,
adenylate kinase, long-chain acyl CoA as well as the action of other molecules including
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neurotransmitters or hormones to reduce ATP-mediated channel inhibition in these cells (Remedi
and Koster, 2010).
2.3.7 Regulation of KATP channel by vasodilators and vasoconstrictors
Since vascular KATP channels are not a typical ―ATP-sensitive‖ K+ channel, vasodilators
and vasoconstrictors have been suggested to be the major players affecting the activity of these
channels. The potent endogenous vasodilator calcitonin gene-related peptide (CGRP), found in
perivascular nerves, activates KATP channels of coronary arteries or mesenteric arteries (Miyoshi
and Nakaya, 1995; Nelson et al., 1990). Since the receptors of CGRP are G-protein coupled
receptors, the activation of KATP channel is probably mediated through the PKA signaling
pathway. More recent studies in our lab indicate that isoproterenol (Isop) activates the vascular
KATP channel and leads to vasodilation (Shi et al., 2007b; Yang et al., 2008; Zhang et al., 2010b).
This effect relies on the activation of PKA signaling pathway modulating the SUR2B subunit
(Shi et al., 2008a). In contrast, the vasoconstrictor arginine vasopressin (AVP) inhibits the
vascular KATP channel mainly through PKC signaling pathway modulating Kir6.1 subunit (Shi et
al., 2007a). Nitric oxide (NO) is also an important vasodilator, however, its effect has only been
observed in Kir6.2 but not in Kir6.1 containing channels. In this dissertation, we tested the effect
of another important peptide hormone, vasoactive intestinal peptide (VIP), on the KATP channels.
2.3.8 KATP channel knockout mice
KATP channels are made up of pore-forming Kir6.x (6.1 or 6.2) and regulatory SURx
(SUR1 and SUR2). Mice lacking any of the four essential genes of KATP channels have been
generated and studied. Kir6.2 and SUR1 knockout mice have impaired glucose homeostasis
(Miki et al., 1998; Shiota et al., 2002). Mice without either Kir6.2 or SUR1 have transient
31

neonatal hypoglycemia (Seghers et al., 2000). In stress conditions, Kir6.2 knockout mice have an
abnormal prolongation of the action potential of the heart with strong Ca++ overload, which leads
to heart failure and death (Yamada et al., 2006). Kir6.2 is also expressed in the brain, and the
Kir6.2 knockout mice have been observed to be susceptible to seizure after brief hypoxia
(Yamada et al., 2001). The knockout of Kir6.1 or SUR2 causes the coronary artery impairments
(Chutkow et al., 2001; Miki et al., 2002). Specifically, the Kir6.1 knockout mice develop
Prinzmetal angina and have a very high risk of sudden death. They also have spontaneous
elevation of S-T segments followed by an atrioventricular block. These syndromes indicate that
the problem of sudden death is likely due to myocardial ischemia in these knockout mice.
2.3.9 KATP channelopathies
The mutation of KATP channels are identified in many diseases and more importantly, the
causality link has been established between the mutations of KATP channels and these diseases.
One of the most popular diseases caused by KATP channel mutation is neonatal diabetes mellitus.
This diseases is a rare disorder that refers to diabetes diagnosed within 6 months of birth
(Flanagan et al., 2006). The mutations of KATP channels contribute to roughly 40% of the
diagnosed cases of permanent neonatal diabetes. In physiological conditions, the glucose is uptaken into the β cells via the GLUT2 transporter. Glucose is then metabolized, resulting in an
elevation of intracellular ATP concentration. The binding of ATP to the Kir6.2 subunit of the
KATP channel leads to the channel closure. The closure of KATP channel causes membrane
depolarization, triggers the activation of VACC, induces Ca++ influx and eventually insulin
secretion. The gain-of-function mutations of either Kir6.2 or SUR1 subunits result in a KATP
channel with a higher intrinsic open probability than the WT, making the channel less sensitive
to the ATP-mediated inhibition. The impaired channel closure disrupts the insulin secretion,
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resulting in diabetes. While most of the gain-of-function KATP channel mutations lead to
diabetes, a small number of the patients develop a more severe syndrome called severe
developmental delay and epilepsy syndrome (DEND) in addition to neonatal diabetes. This
becomes the case when the mutations occur at a very critical site affecting the channel gating or
other essential features. Strikingly, it has been reported that ~90% of DEND syndrome patients
bear Kir6.2 mutations (Edghill et al., 2010).
The loss-of-function mutations of either Kir6.2 (KCNJ11) or SUR1 (ABCC9) of the KATP
channel are one of the most popular causes of persistent hyperinsulinemic hypoglycemia of
infancy (PHHI), characterized by uncontrolled secretion of insulin. The hypoglycemia associated
with this disease irreversibly damages the brain. Mutations of K ATP channels (~200 distinct
mutations) account for ~70% of all PHHI cases. These mutations affect several different aspects
of KATP channels: one group of mutations affect the membrane expression of KATP channels
(Ashcroft, 2005), another group of mutations cause the inactivity of the KATP channels (Ashcroft,
2005), and the third group disrupts the channel sensitivity to nucleotides (Remedi and Koster,
2010).
Besides the dysfunction of KATP channel in β-cells, recent studies indicate that frameshift and missense mutation of SUR2A genes in patients lead to dilated cardiomyopathy
(Bienengraeber et al., 2004). Unlike other diseases caused by mutations of KATP channel, the
underlying mechanism and the causality link in the SUR2A mutations and frame-shift have not
been established.
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2.4 Protein Posttranslational Modification: PKA
2.4.1 Definition of the posttranslational modification
Protein posttranslational modifications (PTMs) refer to the later steps in protein
biosynthesis and can be used to describe any protein modifications that occur after the
maturation of the proteins. In general, these modifications involve chemical reactions to form
covalent bonds between proteins and small biological molecules (except the formation of
disulfide bond between two cysteine residues). PTMs can be divided into two groups. The first
group of PTMs occurs constantly and routinely after the protein biosynthesis and is an essential
step towards the maturation of the proteins. For example, after the biosynthesis, insulin is cut
twice after the formation of disulfide bonds, followed by removal of a propeptide for maturation.
The second group of PTM occurs only in response to the specific stimuli, changing the behavior
of the proteins or altering the function of the proteins (e.g. protein phosphorylation). This group
of PTMs often involves the addition of functional groups (Zhang et al., 2010a). Many PTMs are
facilitated by specific enzymes while others are through non-enzymatic reactions (e.g.
oxidization reaction). The first group of PTMs does not fit in the scope of our study therefore we
will mainly focus on the second group of PTMs.
Over hundreds different PTMs have been identified, while more than a dozen of them
have been observed in in vivo conditions (Zhang et al., 2010a). The biologically relevant PTMs
involving the addition of functional groups includes: acetylation, methylation, glycosylation, Snitrosylation, S-glutathionylation, phosphorylation and many more. PTMs also involve the
addition of peptides including different ubiquitins (Bhave and Gereau, 2004; Rougier et al.,
2010).
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2.4.2 Protein phosphorylation as a PTM in physiological condition
Protein phosphorylation is by far the most well understood PTM, in which a phosphate
(PO4) group is added to the proteins (Ubersax and Ferrell, 2007). Phosphorylation is found in a
large number of proteins involved in virtually all cellular processes. Phosphorylation of a protein
can be achieved by the action of protein kinases like PKA, PKC and PKG and many others.
Protein phosphorylation occurs on specific residues (serine, threonine and tyrosine). The protein
kinases often recognize certain motifs but many phosphorylation sites reported do not fully fall
into the classic consensus amino acid sequences. In this dissertation, we studied how VIP
activates the vascular KATP channel through the PKA signaling pathway.
2.4.3 Neurotransmitters
Receptor-mediated intracellular signaling often leads to protein phosphorylation,
especially the metabotropic receptors. The binding of the ligands to the receptor activates the Gprotein and further triggers the intracellular signaling cascade, for example, the PKA signaling
system. Another type of receptors is ionotropic receptors, which acts as a ligand-gated ion
channel, directly converting the signals from neurotransmitters to the gating of ion channels.
Their signaling may lead to protein phosphorylation as well, through other signaling molecules
such as Ca++.
Many neurotransmitters, including glutamate (Glu), serotonin (5-HT), acetylcholine
(Ach), gamma-aminobutyric acid (GABA), adenosine triphosphate (ATP) have both ionotropic
as well as metabotropic receptors. On the contrary, others (dopamine, norepinephrine,
epinephrine, vasoactive intestinal peptide) are known to be associated only with metabotropic
receptors. Glycine is among the few neurotransmitters that are only found to be associated with
ionotropic receptors.
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Ionotropic receptors are further divided depending on the type of ions passing through.
For example, NMDA and AMAP receptors (bind to Glu); Nicotinic acetylcholine receptor, (bind
to Ach); 5-HT3 (bind to 5-HT); P2X (bind to ATP), are a group of ionotropic receptors that
conduct cations. Glycine receptors (bind to Gly); GABAa receptors (bind to GABA) are a group
of ionotropic receptors that conduct anionic (Cl─) currents.
2.4.4 GPCR signaling pathway
GPCRs are a large group of receptors that are coupled to a variety of signaling pathways
including PKA and PKC. The binding of ligand (neurotransmitters, hormones, etc) to the specific
GPCR initiates the cascade. The activation of GPCRs through receptor-ligand interaction leads
to the conformational change of the GPCRs, and actives the G protein. Several different Gproteins exist that are associated with different GPCRs. The G proteins are divided into Gα and
Gβγ. Gαs and Gαi/o proteins are involved in cAMP dependent pathways. Gαs activates the
adenylate cyclase (AC) and leads to the conversion of cytosolic adenosine triphosphate (ATP) to
cAMP, whereas Gαi/o inhibits the AC activity and leads to the decrease in cAMP level. Since
the activity of Protein kinase A relies on the levels of cAMP, GPCR associated Gαs and Gαi/o
trigger the downstream signaling pathways mainly through the regulation of PKA activity. Gαq/11,
on the other hand, activates phospholipase C-β, which in turn cleaves the membrane bound
phosphatidylinositol 4,5-biphosphate (PIP2) and make inositol (1,4,5) triphosphate (IP3) and
diacylglycerol (DAG). IP3 binds to IP3 receptors of the endoplasmic reticulum (ER) and cause
the release of Ca++ from the ER into the cytoplasm. DAG that remains bound to the plasma
membrane activates several membrane localized forms of PKC. Many isoforms of PKC can also
be activated by an increase of intracellular Ca++ level. These two pathways converge together to
activate the PKC signaling pathway. Gα12/13 is coupled to RhoGEFs (p115-RhoGEF, PDZ36

RhoGEF and LARG), activating small GTPase. Other G proteins exist including Gβγ. These G
proteins mainly target the ion channels including the GIRK (G-protein coupled inwardly
rectifying K+ channels) and P/Q- or N-type voltage gated Ca++ channels.
2.4.5 PKA consensus sequence
Protein kinase A preferentially phosphorylates the serine and threonine residues in a
protein. The consensus sequence for PKA has been shown to be (R-R-X-S/T-Φ, where S/T is a
serine/threonine phosphorylation site and Φ represents a hydrophobic amino acid residue). The
S/T phosphorylation site is referred to as P, the first residue C-terminus to the P is P-1 while the
first residue N-terminus of P is referred as P+1, and so on for the remaining residues on both
sides of P. The crystal structure of PKA bound with PKI (non-phosphorylatable substrate
mimetic) has been resolved, which provides structural explanation for this consensus sequence
(Ubersax and Ferrell, 2007).
Several key structural elements in PKA that limit the choice for potential substrates have
been identified based on the charge and hydrophobic interactions. Two Glutamic acid (Glu)
residues in PKA protein form anionic binding sites for the P-2 and P-3 positions of the substrate.
A hydrophobic pocket serves as a high affinity site for a hydrophobic residue in the P+1 position.
The consensus sequence of the substrate for PKA fits well into the local structure and provides
the primary specificity for the substrate and kinase interaction. Other residues in the substrate
also contribute to the binding of PKA and its substrates. These residues sometimes are farther
from the active site so that this could be a key factor to explain why some phosphorylation sites
do not fully fall into the classic motifs R-R-X-S/T-Φ (Ubersax and Ferrell, 2007).

37

2.5 PTM: S-glutathionylation
2.5.1 Oxidative stress overview
Oxidative stress is the condition in which the excessive ROS production overwhelms the
cellular anti-oxidant system (Madamanchi et al., 2005). Oxidative stress is also referred to as a
condition that can cause pathological PTMs. Several endogenous ROS exist including
superoxide (O2˙─), hydroxyl radicals (˙OH), hydrogen peroxide (H2O2), and ozone (O3) (Powers
and Jackson, 2008).
Oxidative stress is known to cause protein dysfunction by the action of excessive ROS,
affecting mainly the cysteine residues of proteins. In the cardiovascular system, oxidative stress
plays a leading role in hypertension, arteriosclerosis and other cardiovascular diseases by
affecting the key molecules involving in physiological regulation of blood vessel tone. Many key
molecules, including vascular KATP channels, have been found to be targeted by ROS. In the
coronary arteries of diabetic patients (Miura et al., 2003) and cerebral arterioles from the rat
(Erdos et al., 2004; Ross and Armstead, 2003), the inhibition of KATP channel by oxidative stress
or ROS is also seen(Ichinari et al., 1996; Krippeit-Drews et al., 1999). Therefore, fundamental
questions remain open as to which isoforms of KATP channel are targeted by oxidative stress, and
what molecular mechanisms underlie the KATP channel modulation.
2.5.2 Reactive oxygen/nitrogen species
Superoxide is an intermediate in many biochemical reactions. Compared with other free
radicals, it has a relatively long half-life and can diffuse away from its original source to modify
proteins in a distinct location. It is membrane impermeable and relatively less reactive than ˙OH.
Superoxide rapidly reacts with NO or iron-sulfur containing proteins forming ONOO─ or ˙OH.
Dismutation of O2˙─ by superoxide dismutase (SOD) is a major source of endogenous H2O2.
38

H2O2 is the most stable endogenous ROS. It can pass through plasma membranes across
water channels and chloride channels. Compared with other ROS, H2O2 is a relatively weak
oxidizing agent. Catalase (Cat) is the primary enzyme reducing the endogenous H 2O2 to water
and O2 (Madamanchi et al., 2005). In this dissertation, we mainly used H2O2, an endogenously
existing ROS, to induce oxidative stress, and tested how the oxidative stress affects the function
of vascular KATP channels.
Hydroxyl Radicals is the most reactive ROS and the strongest oxidizing agent. ˙OH has a
very short half-life and is membrane impermeable. It is the most damaging ROS that exist
endogenously. However, due to its high reactivity and extreme short half-life, the reliable
methods to measure the ˙OH are limited and indirect, making it difficult to attribute directly the
damaging effect of ROS to ˙OH (Madamanchi et al., 2005).
2.5.3 S-glutathionylation
S-glutathionylation is a post-translational modification mechanism of proteins at the
cysteine residues by adding a glutathione (GSH) moiety (Dalle-Donne et al., 2008). Protein Sglutathionylation is facilitated by the oxidative stress when excessive ROS are present and GSH
is available. S-glutathionylation allows the regulation of a large number of cellular processes by
modulating proteins to alter their functions. Before S-glutathionylation mechanism is identified,
the general idea for oxidative stress or ROS/RNS mediated protein modification was thought to
be mediated through the formation of disulfide bonds or sulfenic acid intermediates like (–SOH,
–SO2H or –SO3H acids). However, since GSH is abundant within the cells, GSH is likely to
serve as a major electron donor to ROS and make S-glutathionylation a dominate mechanism
underlying the protein modification in oxidative stress.
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2.5.4 Sulphydryl or thiol groups (–SH) as reactive center
Thiol group is susceptible to oxidative modification. In biological system, it exists in
cysteine residues of proteins or in small molecules like glutathione and dihydrolipoic acid. Upon
redox reaction, the thiol group is modified in response to the stimuli and local environment and
thus affects the function of the proteins having such accessible thiol groups. Depending upon the
nature of stimulation, different modification may occur. (1) ROS may cause the formation of
disulfide bond between two cysteine residues within a protein or between two disparate proteins.
(2) In the presence of certain amount of GSH, ROS stimulation may lead to S-glutathionylation.
(3) In the presence of NO, ROS stimuylation may cause S-nitrosylation. (4) Oxidation of
cysteine residues may also result in the sequential formation of cysteine radicals (P-S˙), followed
by sulphenic (PS-OH), sulphinic (PS-O2H) and eventually sulphonic (PS-O3H) acids. The last
two reactions are irreversible. In this dissertation, we tested if S-glutathionylation is the
molecular mechanism underlying the channel inhibition under oxidative stress (Dalle-Donne et
al., 2008).
2.5.5 Glutathione
Glutathione exists in virtually all cells in the millimolar concentration range. It is the
major non-protein thiol compounds that act as an inherent antioxidant, and work together with
oxidized glutathione (GSSG) as intracellular redox buffer (Dalle-Donne et al., 2008). GSH is a
tripeptide, containing a cysteine, a glutamate and glycine through unusual peptide bonds, in
which the carboxyl group of the glutamate side-chain is linked to the amine group of cysteine.
The carboxyl group of cysteine is linked to the amine group of glycine in a conventional manner.
In mammalian cells, the concentration of GSH ranges from 1~5 mM depending on the cell types.
Most of them exist in the form of GSH and a small portion of them exist as GSSG. In
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physiological conditions, the GSH: GSSG ratio is around 50:1 to 100:1 but this ratio can change
drastically in pathological conditions e.g., oxidative stress. ROS trends to accept electrons so that
GSH is an antioxidant by serving as an electron donor. In this process, glutathione is turned into
GSSG.
2.5.6 Antioxidant and deglutathionylation enzyme
Protein deglutathionylation is catalyzed by specific enzymes. Glutaredoxin (Grx) is
suggested to be the major deglutathionylation enzyme in mammalian cells (Meyer et al., 2009;
Mieyal et al., 2008). The mammalian cytosolic form of Grx (Grx1) is exclusively selective for
protein-SSG compared with other forms of disulfides (e.g. S-S disulfide bond, S-nitrosylation,
etc.). It is very effective in reducing protein-SSG, thus is considered as a specific
deglutathionylating enzyme. Moreover, in Grx1 knockout mice, no deglutathionylating activity
was detected (Meyer et al., 2009), further supporting its critical role. Therefore, we used Grx1 to
test whether S-glutathionylation mediated channel inhibition is reversible.
Besides Grx1, other enzymes have been implied in deglutathionylation or serving in
antioxidant defense system, including thioredoxin (Trx2), peroxiredoxins (Prx3/5), thioredoxin
reductase (Trxr2), glutathione reductase (GR) and etc. However, the specificity and the specific
substrates of these enzymes are still not well understood (Lin and Beal, 2006).
2.5.7 Specificity of protein S-glutathionylation
The specificity of protein S-glutathionylation has not been fully understood and is still
under wide debate (Dalle-Donne et al., 2008). In general, it is believed that not all cysteine
residues are equally susceptible to S-glutathionylation upon the same stimuli (e.g. GSSG).
However, no consensuses motif has been found relating to S-glutathionylation. S41

glutathionylation is mediated by oxidants and so far no strong evidence indicating enzymes can
facilitate this process.
Several different contributing factors conferring specificity have been pointed out.
Firstly, the accessibility of the thiol group of a given cysteine residue in the protein threedimensional structure is the primary factor determining if the thiol of this cysteine could undergo
S-glutathionylation. The reactivity of the cysteine residues is another determining factor
depending on its adjacent residues or microenvironment. It has been suggested that if the
cysteine is surrounded with positive charged residues, it is more reactive because a P-S˙ may
form through the interaction of the thiol group with the charged residues. Another words, a
cationic environment can make the –SH group particularly susceptible to S-glutathionylation.
Thirdly, the helix-dipole effect has been indicated to contribute to the reactivity of the cysteine
residues, which could lower the pKa of cysteine residues. Moreover, cysteine residues form
hydrogen bonds with charged residues e.g. Ser or His, selenocysteine residues or cysteines bound
with metal ions, e.g. Mg++, Ca++ or Zn++ are also readily to be S-glutathionylated (Dalle-Donne et
al., 2008).
2.5.8 Structure impact of protein S-glutathionylation
Protein S-glutathionylation results in the incorporation of a GSH moiety to the protein
cysteine residue. This incorporation depends on the location of the cysteine and may affect the
protein structure directly. Consequently, the charged group of GSH and the charged groups
around the cysteine residue may interact with each other to affect the protein structure. In either
case, the S-glutathionylation mediated structural changes may lead to alteration of protein
functions. To understand how the S-glutathionylation structurally affects the protein function, the
availability of the crystal structure of the target protein is essential. Structural insights have been
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gained through the modeling of pore forming Kir6.1 subunit of KATP channel using the crystal
structure of bacterial and chicken Kir channel as templates in this dissertation.
2.5.9 S-glutathionylation of ion channels
S-glutathionylation of RyR
Ryanodine receptor (RyR) is the first ion channel found to be S-glutathionylated, as well
as S-nitrosylated (Sun et al., 2001b, 2003). Expressed on the endoplasmic reticulum (ER), the
RyR is responsible for the Ca++ release from ER to cytosol. The RyR protein has ~100 cysteine
residues and is highly sensitive to oxidation. Both S-glutathionylation and S-nitrosylation could
occur on RyR channels: It has been reported that GSSG and H2O2 enhance the channel activity
by reducing the Mg++ mediated inhibitory effect while NO donor NOR-3 enhances the Ca++
mediated activation of channel kinetics. GSNO, which can cause both S-glutathionylation and Snitrosylation, produces both effects. (Aracena et al., 2003). Further study has demonstrated that
certain cysteine residues (Cys1040 and Cys1303) are exclusively S-nitrosylated, and some
(Cys1593 and cys3193) are selectively S-glutathionylated, while others can undergo both
reactions (Aracena-Parks et al., 2006). However, these studies open interesting questions: How
can S-nitrosylation and S-glutathionylation selectively occur on certain cysteine residues? Do
these modulations occur in the similar manner in the in vivo condition? How does S-nitrosylation
compete with S-glutathionylation for the same residue? What are the determinants for the
reaction? What is the physiological significance for the presence of such complicated modulation
systems?
S-glutathionylation of CFTR
Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel
belonging to the ABC transporter family. CFTR regulates the salt and water transportation across
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epithelial membranes in the lung and gut. Mutations of CFTR gene can lead to cystic fibrosis and
congenital bilateral absence of vas deferens. During inflammation, ROS produced target the
epithelial cells and modulate the plasma membrane-bound CFTR. Indeed, Wang et. al., found
several oxidized forms of glutathione including GSSG (10~20 mM), and nitrosylated
glutathione/S-nitrosoglutathione (GSNO, 50~200 µM) that can inhibit the channel activity
markedly in excised patch recordings. Moreover, the combined application of glutathione and
diamide (5~100 µM, equimolar), an S-glutathionylation induction method, can also cause
marked channel inhibition. These reactions could be rescued by the reducing agent dithiothreitol
(DTT, 20 mM) and deglutathionylation enzyme glutaredoxin (Grx, 4 µM). In addition,
biochemical experiments further demonstrate that diamide (100 µM) facilitates the incorporation
of biotin-GSH (125 µM) to CFTR protein, which could be pulled down by streptavidin and be
further detected by western blot. Using mutagenesis, Cys344 located in the NBD2 domain is
identified as the primary site for S-glutathionylation. This modulation potentially affects the
nucleotide binding and disrupts the ATP-dependent channel opening. The data demonstrate that
CFTR is S-glutathionylated in their experimental conditions. However, this study does not rule
out the possibility that the naturally occurring GSNO can also cause S-nitrosylation to inhibit the
channel activity. Moreover, additional studies using naturally occurring ROS including H2O2 or
XO/X system that are of physiological relevance in addition to diamide will be needed (Wang et
al., 2005).
S-glutathionylation of CRAC channel
Ca++ release-activated Ca++ (CRAC) channels belong to store-operated channels, which
play important roles in a variety of signaling cascades of non-excitable cells, including T
lymphocytes and mast cells. Recent studies have identified Orai1 (Ca++ release-activated Ca++
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modulator) as the pore-forming subunit of CRAC channel while Stromal-interacting molecule
(STIM) as the endoplasmic reticulum (ER) Ca++ sensor. Upon Ca++ store depletion, STIM1
which is located in ER undergoes oligomerization and redistributed to the location that is within
10-25 nm of the plasma membrane (Penna et al., 2008; Prakriya et al., 2006). With such a short
distance, STIM1 on the ER is able to bind to Orai1 directly and causes its activation, leading to
Ca++ influx (Park et al., 2009a). In oxidative stress, the impairment of Ca++ signaling has been
observed but the underlying mechanism is not clear (Bogeski et al., 2010). Hawkins et. al.,
reported that oxidative stress, induced by Lipopolysaccharide (LPS) (1.5 µg/ml), H2O2 (100 µM)
or buthionine sulfoximine (BSO, 200 uM, γ-glutamyl synthetase, the rate-limiting enzyme in
GSH synthesis, inhibitor) alter the Ca++ signaling in B-lymphocytes by oxidizing the glutathione
and through the modification of the CRAC channels (Hawkins et al., 2010). They further
identified that the ER-resident STIM1 is S-glutathionylated by pull-down experiment. STIM1 is
immunoprecipitated with α- STIM1 antibodies and then probed for S-glutathionylation with a
peptide antibody against GSH. A conservative cysteine residue (Cys56) is further identified as
the target of S-glutathionylation. The addition of GSH to STIM1 is further confirmed by mass
spectra. The S-glutathionylation of STIM1 results in a constitutively activated CRAC channel.
This paper provides good evidence indicating that S-glutathionylation occurs on the Cys56 of
STIM1. However, since the truncated STIM1 (N-terminal region) is used for the experiment, it is
not known if other cysteine residues in STIM may also be S-glutathionylated. Moreover, since
this region is located within the ER lumen, the concentration of GSH and the ratio between
GSH/GSSG is not known, call for further experiments. This paper also fails to rule out the
involvement of Orai S-glutathionylation, which could also be possible.
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S-glutathionylation of channels for Ca++ homeostasis
Intracellular Ca++ concentration and Ca++ oscillations play important roles in endothelial
cells, including the regulation of vascular permeability, inflammation, etc. The disruption of Ca++
homeostasis has been associated with oxidative stress, whereas the molecules that are directly
targeted by ROS are not clear. Lock et. al., demonstrate that diamide, a thiol-oxidizing agent,
could increase the intracellular Ca++ concentration and oscillations (Lock et al., 2011). The
authors further demonstrate that this modulation is related to glutathione by using N,N’-bio(2chloroethyl)-N-nitrosourea (BCNU), an inhibitor of glutathione reductase and L-buthioninesulfoximine (BSO), which could inhibit the γ–glutamylcysteine synthetase. They further
identified that IP3 receptors and plasmalemmal Ca++-ATPase (PMCA) pump are the molecules
targeted by ROS and tested the hypothesis that the modulation of these two molecules is through
S-glutathionylation using pull-down experiments with BioGEE. Based on their data, they
conclude that S-glutathionylation occurs on IP3 receptors and PMCA pumps to enhance the
activity of the former but decrease the activity of the later. This study provides the first pieces of
evidence about the S-glutathionylation of IP3 and PMCA pump but further studies are definitely
needed to dissect the detailed modulation mechanism, especially of the cysteine residues.
Although diamide has been used extensively in the experimental condition as a strong oxidizing
agent, but it is not an endogenous substance. It would be interesting to see if the similar
responses described in this report could be obtained using more rigid methods and stimuli that
are more physiologically relevant (e.g., H2O2, ONOO─, etc.) to induce S-glutathionylation (Lock
et al., 2011).
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2.6 Other forms of ion channel PTMs
2.6.1 Ion channel S-nitrosylation
S-nitrosylation is referred to as the addition of an NO to the thiol moiety of a cysteine
residue. S-nitrosylated Cysteine residues are often found in an acid-base motif with an acidic
amino acid (D/E) in the +1 amino acid (AA) next to the cysteine residue being critical (Gonzalez
et al., 2009).
Specificity of this regulation is partially contributed by the spatial co-localization of the
target proteins with nitric oxide synthases (NOSs), the enzymes that generate NO in vivo. No
enzyme that can facilitate the formation of protein S-nitrosylation has been found. Enzymes like
S-nitrosoglutathione reductase (GSNOR) and thioredoxins (Trx1 and Trx2) have been shown to
mediate the de-nitrosylation. Several methods including biotin switch protocol (Forrester et al.,
2007; Jaffrey and Snyder, 2001), photolysis chemiluminescence (Xu et al., 1998) and antibodies
against S-nitrosocysteine moiety (Aracena et al., 2005) have been developed to detect the Snitrosylation.
A large number of ion channels have been identified to undergo S-nitrosylation. RyR is a
well demonstrated example for S-nitrosylation. The RyR located on the SR membrane mediates
Ca++ release of SR in response to Ca++ influx through plasma membrane Ca++ channel. RyR has
~100 cysteine residues and about half of them are reactive. Some of them are found to be Snitrosylated and others are S-glutathionylated, respectively. The S-nitrosylation occurs on
Cys3635 of RyR1, which is located within a hydrophobic motif (Sun et al., 2001a). The different
effects of NO on RyR are attributed largely to the specific types of NO donors, the concentration
of the NO donor and the channel redox state (Gonzalez et al., 2008).
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S-nitrosylation occurs on voltage-gated Na+ channel NaV1.5 (SCN5A), a channel
responsible for fast depolarization in C-type DRG neurons. S-nitrosylation of this channel is
responsible for the persistence of NaV1.5 current in cardiac myocytes and inhibition of the
currents in sensory neurons (Renganathan et al., 2002). Voltage-gated K+ channels, which
determine the resting membrane potential, have been found to be S-nitrosylated. In KCNQ1
channel, S-nitrosylation has been found to occur at Cys445, located within a consensus motif
(Asada et al., 2009). KV1.5, which generates the ultra-rapid component of the delayed rectifier
(Ikur), is inhibited by S-nitrosylation. Based on the modeling studies, it is suggested that the Snitrosylation of two cysteine residues located in the voltage-sensor region of the channel affect
the channel conformational change (Nunez et al., 2006).
Transient receptor potential (TRP) channel family is a group of cation channels that play
important roles in a variety of cellular processes by mediating the Ca++ signaling (Clapham,
2003). S-nitrosylation modulation has been tested on all the members of TRPC branch (TRPC1TRPC7) and interestingly, only TRPC3 has been shown to respond to the NO donor SNAP (300
µM) and H2O2 (1 mM) significantly. Further test using reactive disulfides, mutagenesis as well
as biochemical experiments demonstrate that the NO mediated TRPC channel modulation is
through S-nitrosylation of TRPC5 at a conserved site Cys558. Structural modeling shows that
this site is located at the pore-forming helix, and the S-nitrosylation of which cause the bend of
the helix leading to channel opening (Yoshida et al., 2006).
It is worth noting that S-nitrosylation and S-glutathionylation shares lots of common
features: they are both facilitated by oxidants; they all target the cysteine residues and attach a
moiety to the cysteine residues. Therefore, in the experimental condition, reactive disulfides can
be used to mimic both S-nitrosylation and S-glutathionylation. Moreover, studies have shown
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that for a given protein, S-nitrosylation and S-glutathionylation both could occur depending on
the specific cysteine residues and the redox state of the proteins (Aracena-Parks et al., 2006).
Standard protocols and testing strategies should be carefully evaluated and established to guide
potential future studies to further distinguish between the S-nitrosylation and S-glutathionylation.
2.6.2 Ion channel S-palmitoylation
Protein S-palmitoylation refers to the formation of a reversible thioester linkage of a 16
carbon palmitate lipid to an intracellular cysteine residue. This modification has been shown to
control the maturation, trafficking and the regulation of ligand- and voltage- gated ion channels.
It has also been shown to affect the channel modulation by other signaling molecules (Shipston,
2011). This modulation is reversible. The enzymes that facilitate this modulation are called
palmitoyl acyltransferases and zDHHC (zinc finger- and DHHC domain- containing proteins)
while the de-palmitoylation is achieved through the enzyme (palmitoyl thioesterases). The major
effect of palmitoylation is to increases the hydrophobicity of the target protein, which may affect
the function of ion channels in a variety of aspect including their surface expression and intrinsic
activity.
For example, palmitoylation has been shown to affect the trafficking and surface
expression of ion channels including NaV1.2 and KV1.6, NMDA receptors, BK channels and
many more. On the other hand, palmitoylation can also modulate the channel activity, like the
intrinsic voltage sensitivity of KV1.1 channel (Gubitosi-Klug et al., 2005), gating of epithelial
Na+ channel (Mueller et al., 2010) and voltage-dependent inactivation of N-type Ca++
channels(Stephens et al., 2000).
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Besides, there is a potential crosstalk or interaction between palmitoylation and other
PTMs. It has been further suggested that palmitoylation inhibits the channel phosphorylation by
PKC through steric hindrance and promotes channel phosphorylation in some other cases.
Although no ―consensus‖ motif for protein palmitoylation has been identified, some
factors critical for the cysteine palmitoylation (Fukata and Fukata, 2010) have been found. The
local concentration of fatty acyl-CoA close to the reaction site, the local environment of the
target cysteine and the accessibility of the cysteine, whether there are basic or hydrophobic
residues around it can determine whether palmitoylation is likely to occur or not (Belanger et al.,
2001).
2.6.3 Ion channel SUMOylation and Ubiquitylation
Ubiquitylation is mainly involved in the degradation pathways through internalization
and targeting of membrane proteins to the lysosome. Ubiquitin is a small protein of 7kDa,
activated by an enzyme called E1 and then transferred by E2 to E3. The interaction of E3
ubiquitin ligases with their substrates would add an ubiquitin to the lysine residues of the target
proteins. Targeted proteins can be attached with either mono- or multiple- ubiquitin proteins
(Rougier et al., 2010).
The SUMOylation pathway, however, is involved in many cellular functions. It often
associated with transcriptional activity. SUMO stands for Small Ubiquitin-related MOdifier.
SUMOylation usually occurs on lysine residues that fit into the consensus motif of ψ-K-X-E/D
(ψ represents aliphatic acid and X represent any amino acid). De-SUMOylation requires a group
of enzymes called SENP (SUMO/sentrin-specific protease)
Many ion channels have been shown to undergo Ubiquitylation. For example, NaV 1.5, a
major voltage-gated Na+ channel in cardiac muscle, is ubiquitylated. This modification depends
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on the ubiquitin ligase nedd4-2, a member of the Nedd4 (neuronal precursor cell
developmentally downregulated 4) family. Nedd4-2 enhances the internalization rate of NaV 1.5
channel (Rougier et al., 2005; van Bemmelen et al., 2004). However, how this regulation affects
the cellular function is still not clear. KCNQ1 channel mediated the delayed rectifier K+ current
Iks, playing a key role in the action potential repolarization phase. The delayed rectifier K+
current (Iks current) density is shown to be reduced by many Nedd4 family members without
altering its biophysical properties (Jespersen et al., 2007). Human ERG1 channel encodes the αsubunit of the cardiac K+ current delayed rectifier Ikr. The trafficking of hERG1 is strongly
associated with the ubiquitylation.
Channel SUMOylation has been initially identified in the K2P1 channel. K2P1 is a
background leaking K+ channel, with two pore-forming P loops in each subunit. Two subunits
form a functional channel. These channels play important roles in setting the resting membrane
potential of the cells and control the cell excitability. K2P1 gene does not produce currents in
experimental conditions, although its mRNA has been well detected. It is later shown that
SUMOylation of the K2P1 channel is the reason for its silencing and de-SUMOylation of this
channel using SENP-1 would increase the channel activity (Rajan et al., 2005). However, these
findings are later challenged by other groups (Feliciangeli et al., 2007) and the debates are still
going on with new evidence emerging (Feliciangeli et al., 2010; Plant et al., 2010). Moreover,
SUMOylation has been found on KV2.1 channel, where this modification inhibits the current of
KV2.1 to affect the cellular excitability and action potential (AP) (Dai et al., 2009). KV1.5
channel is critical for atrial AP repolarization and the sumoylation of this channel induces the
alteration of the steady-state inactivation of this channel but does not cause any change in current
density (Benson et al., 2007).
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2.6.4 Ion channel O-GlcNAcylation
O-linked β-N-acetyl-glucosamine (O-GlcNAc) glycosylation (O-GlcNAcylation) is a
PTM which differs from the ―classical‖ N-linked glycosylation. It occurs on cytoplasmic
proteins, membrane proteins at the cytosolic side and also nuclear proteins (Hurtadoguerrero et
al., 2008). It modifies serine and threonine residues by O-linked attachment of a single β-Nacetyl-glucosamine moiety. UDP-GlcNAc, an end product of the hexosamine biosynthetic
pathway, is the substrate for O-GlcNAcylation. O-GlcNAcylation is reversible reaction,
facilitated by the enzyme O-β–N-acetylglucosaminyltransferase (OGT) and removed by O-β–
Nacetylglucosaminidase (OGA). O-GlcNAcylation is highly associated with pathological
conditions and also is serves a sensor of cellular stress. The substrate of O-GlcNAcylation, UDPGlcNAc, increases significantly in hyperglycemia, hyperlipidemia and diabetes conditions.
Stress conditions like oxidative stress, nutrient stress and thermal stress can induce OGlcNAcylation.
Since O-GlcNAcylation occurs on serine and threonine residues similar to protein
phosphorylation, interplay between O-GlcNAcylation and phosphorylation has been suggested
(Wang et al., 2008). As a result, O-GlcNAcylation mediated protein modification could either
block or promote the phosphorylation on the same site or site at a distant location (Hu et al.,
2010), affecting the protein functions.
Ion channels are critical in maintaining the vascular tones and cardiac contractile. As
vascular and cardiac dysfunctions have been linked with hyperglycemia and diabetes, (Chatham,
2010; Clark, 2003; Lima et al., 2008b; Lima et al., 2009), it is likely that ion channels could be
the target of O-GlcNAcylation during these pathological conditions (Lima et al., 2008a).
Although more than 100 proteins have been found to be O-GlcNAcylated, the study of O-
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GlcNAcylation on ion channels are still in the state of infancy. To date, only one ion channel for
intracellular Ca++ release (InsP3 receptor I) has been found to be GlcNAcylated (Rengifo et al.,
2007). O-GlcNAcylation decreases the activity of InsP3 receptor type I but increases the activity
of InsP3 receptor type 3. InsP3 receptor type 2 is also found to be O-GlcNAcylated but no
functional consequence has been observed (Bimboese et al., 2011). Functional assays of channel
activities have been obscured due to the low levels of activity of the recombinant OGT enzyme
(Rengifo et al., 2007). With the rapid progress in O-GlcNAcylation research, better reagents and
protocols would surely facilitate the understanding of ion channel O-GlcNAcylation in the near
future.
2.7 The production and action of ROS/RNS
2.7.1 Mitochondrial enzymes
Mitochondria are the metabolic center of the cells and have numerous redox enzymes for
transferring electrons to oxygen and generate reactive oxygen species. A number of enzymes
have been found to generate ROS in mitochondria, which include the enzymes involved in
tricaboxylic acid (TCA) cycle, and the electron-transport chain (ETC) complexes, I, II, and III
(Lin and Beal, 2006). However, under normal physiological conditions, the ROS are rapidly
cleared up by the extensive endogenous anti-oxidant enzymes and molecules. Therefore, both the
membrane bound and soluble proteins and other molecules are protected from oxidative stress
(Lin and Beal, 2006). Mitochondria have a powerful antioxidant defense system which includes
both non-enzymatic and enzymatic components. The former is made of GSH, α-tocopherol
(αTCP), cytochrome C and coenzyme Q10, and the later is made of manganese superoxide
dismutase (MnSOD), catalase (Cat), glutaredoxin (Grx2), thioredoxin (Trx2), and many more.
The detailed functions of these enzymes can be seen in published reviews (Andreyev et al.,
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2005). Among these enzymes, it is clear that Glutaredoxin (Grx2) catalyzes Trx-disulfide
oxidoreduction reactions. It can reduce both protein disulfide and mixed disulfides with GSH,
while thioredoxins efficiently reduce only protein disulfides (Andreyev et al., 2005).
2.7.2 NADPH oxidase
The NADPH oxidase (NOX) family NADPH oxidase generates ROS (mainly O2˙ and
H2O2) through electron transfer from NADPH to molecular oxygen. Superoxide generation by
NADPH oxidase was originally believed to be a unique property of immune cells. The most
well-known NOX is NOX2/gp91phox, firstly demonstrated in professional phagocytes. Many
more NOX family members have lately been identified that make the current NOX a big family.
Like NOX2, the main functions of these proteins are to generate superoxide by transporting
electrons. Since the NOX family has been identified in virtually all cell types, it is clear that the
effect of NAPDH oxidases is not limited to host defense system. Rather, it is shown to be
involved in post-translational processing of proteins, cellular signaling, and regulation of gene
expression (Bedard and Krause, 2007). NOX activity is regulated by Ca++, which is affected by
the membrane excitability of the cells (Sumimoto, 2008).
NOX has been found to regulate ion channels. For example, NOX has been found to
regulate the activity of TASK channel. NOX4 co-localizes with TASK and the overexpressing of
NOX4 and TASK channel in the HEK293 cells reduces the current amplitudes of TASK channel
at both +60 mV and –60 mV voltage conditions. Moreover, the overexpression of NOX4 but not
NOX2 enhances the O2 sensitivity of TASK-1. On the other hand, knockdown of the endogenous
NOX4 expression or the presence of NADPH oxidase inhibitors blunts the O2-dependent
regulation of TASK-1 (Lee et al., 2006). These data indicate that by simply overexpression,
NOX may execute its function. However, this paper does not address whether it is the ROS
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produced by NOX or some other mechanism that affect the sensitivity of TASK-1 to oxygen.
Angiotensin II, which is coupled with the PKC signaling pathway and is a potent vasoconstrictor,
has been suggested to be the most potent inducer of NOX (George and Struthers, 2009).
Therefore, it would be interesting to see if the Angiotensin II treatment could enhance the
phenomenon observed in their studies.
2.7.3 Xanthine oxidase
XO was initially found to be involved in metabolizing hypoxanthine, purine degradation,
and xanthine to uric acid with the generation of superoxide. It was later found to be involved in
ischemia-reperfusion injury, endothelial dysfunction, hypertension and heart failure (Berry and
Hare, 2004). XO is abundantly expressed in liver and small intestine of mammals. However, the
expression of XO is also found in bovine heart, rat heart, and gland, capillary endothelial cells
(Berry and Hare, 2004). Superoxide radicals produced from XO readily react with endothelial
NO to form ONOO─, thereby reducing the bioavailability of NO and impairs vasorelaxation. NO
and superoxide react at an extremely fast rate so even when SOD is present, it would fail to
eliminate superoxide (Cai and Harrison, 2000).
Xanthine (50 µM) plus xanthine oxidase (50 mU ml-1) are the common ways to generate
superoxide (Bielefeldt et al., 1997; Duprat et al., 2005). Other literature shows that XO (0.75
mU/ml) and hypoxanthine HX (125 µM) can not only raise O2˙– levels but also increase H2O2
(Kelley et al., 2010). Since SOD decreases O2˙– and increases H2O2 and catalase decreases H2O2,
using SOD and catalase can provide additional information to further distinguish the
involvement of H2O2 (Juncos and Garvin, 2005).
Besides, other ROS could be generated as follows: Iron catalyzed Fenton reaction with
superoxide generates hydroxyl radicals (Bedard and Krause, 2007). Tert-butyl hydroperoxide
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(tBHP) and H2O2 also produce hydroxyl radicals (Duprat et al., 2005). Rose Bengal can produce
singlet oxygen (1ΔgO2) followed by photo-activation (Duprat et al., 2005).
2.7.4 The combined effect of ROS and NO
ONOO─ is a strong and relatively stable oxidant species (Pacher et al., 2007). ONOO─ is
able to pass the cell membrane to some extent through anion channels. ONOO─ is formed in
tissue by the non-enzymatic interaction between O2˙– anion and NO (Liu et al., 2002). This
reaction is the dominating reaction so that in the presence of ROS, the bioavailability of NO will
drastically decrease, which leads to the impairment of vasodilatation as well as other vascular
diseases. The formed ONOO─ is also a strong reactive species, which reacts with proteins, lipids,
carbohydrates, and nucleic acids leading to the vascular dysfunction. In experimental condition,
NO can be generated using SNP (10 nM) or 3-morpholinosydnonimine (SIN-1, 1 mM) and
superoxide can be made using X/XO system (xanthine, X, 0.1 mM and xanthine oxidase, XO,
0.01 U/ml) (Liu et al., 2002). The combination of these compounds thus would lead to the
formation of ONOO─ (Beckman and Koppenol, 1996; Duprat et al., 2005). ONOO─ can be
synthesized using another published method (Brzezinska et al., 2000).
2.8 Introduction to this dissertation
Evidence by the literature, we have designed a series of experiments in this dissertation.
We found that an exposure of isolated mesenteric rings to H2O2 impaired the KATP channelmediated vascular dilation. In whole-cell recordings and inside-out patches, micromolar H2O2 or
diamide caused a strong inhibition of the vascular KATP channel (Kir6.1/SUR2B) in the presence,
but not in the absence, of GSH, suggesting the involvement of S-glutathionylation. Systematic
mutational analysis revealed three contributing cysteine residues (Cys43, Cys120 and Cys176) to
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be important. Among them, Cys176 was prominent. Simulation modeling of Kir6.1 Sglutathionylation revealed that after incorporation to residue 176 the GSH moiety occupied a
space between slide helix and two transmembrane helices, preventing the necessary
conformational change of the M2 inner helix for channel gating, and retained the channel in its
closed state. We further found that the channel was strongly augmented by VIP and the channel
activation relied on PKA phosphorylation.
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3. SIGNIFICANCE
Cardiovascular diseases (CVD) are a major challenge to modern medicine (Goldberg and
Dansky, 2006; Grundy et al., 2002). A critical stage in the pathogenesis of the diseases is
oxidative stress, a leading contributor to several other diseases including diabetes, inflammation
and neurodegenerative diseases. Oxidative stress results from the over-production of reactive
oxygen, carbonyl or nitrogen species that exceeds the cellular anti-antioxidant defense systems.
Although oxidative stress is widely accepted as the key contributor to the CVDs, non-selective
anti-oxidants treatment fails to improve the outcome of patients with cardiovascular diseases in
clinic trails. This suggests that oxidative stress should not be viewed as an isolated detrimental
factor which can be simply managed by anti-oxidants. Rather, it involves a more complicated
cascade including initiators, mediators and effecters. A deeper understanding of the downstream
molecules that are involved in the sustaining of oxidative stress thus becomes critical. The
investigation of how the reactive species production becomes a cascade may lead to a novel
approach to control oxidative stress and improve the outcome of CVDs.
Previous studies have found that the production of reactive species is closely associated
with membrane excitability (Schilling and Elliott, 1992; Takeya and Sumimoto, 2003; Trebak et
al., 2010). The damaging effects of oxidative stress could be accelerated and amplified in the
condition where the cells are hyper-excitable. Membrane hyper-excitability causes Ca++ influx,
activation of NOX enzyme and more ROS production. Therefore, the functions of key molecules
that regulate membrane excitability may be vital determinants of the extent of oxidative stress.
Their dysfunction can produce persistent depolarization and hyper-excitability, leading to Ca++
overload, more reactive species production, and structural damages.
Vascular KATP channel is a key regulator of membrane excitability. The activation of
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vascular KATP channel leads to hyperpolarization, reduction of the Ca++ influx and protection
against Ca++ overload. In diabetic patients and laboratory animal models for diabetes and fluid
percussion brain injury, the dysfunction of KATP channels is seen, and oxidative stress is
subsequently developed followed by pathogenesis in multiple organs, especially the vasculature.
Therefore, vascular KATP channel seems to be a central player in this pathological process,
mediating or facilitating the ROS production. Hence, activation of the vascular K ATP channel
might be a potential approach to counteract the cellular hyper-excitability, prevent the ROS
production cascade, and alleviate oxidative stress. VIP, a peptide hormone, is known to be
protective against oxidative stress (Koh et al., 2009; Offen et al., 2000; Steingart et al., 2000; Yu
et al., 2011). In P12 neuroblastoma cells and cerebellar granule neurons, VIP has a protective
role against oxidative stress (Offen et al., 2000). It has been found that VIP protects the STZinduced diabetes mice against oxidative stress and inflammation (Yu et al., 2011). In SMCs,
which are also excitable cells, VIP is likely to protect the cells against oxidative stress as well,
probably by activating the vascular KATP channels.
Considering the potential role of KATP channels in the link of the ROS production and
membrane excitability, the demonstration of how the vascular KATP channel is modulated in
oxidative stress is of critical importance. The understanding of the KATP channel modulation in
oxidative stress may shed new insight into how membrane excitability is affected by oxidative
stress, how the ROS production cascade occurs with hyper-excitability, what is the molecular
basis of KATP channel modulation by different reactive species, and how the cascade can be
interrupted by manipulating the KATP channel activity. The information gained in this study is
not limited to cellular physiology but also have a profound impact on the design of therapeutic
modalities for CVDs and other oxidative stress-associated diseases.
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4. MATERIAL AND METHODS
4.1 Chemicals and reagents.
Unless stated, all reagents and chemicals used in this study were purchased from Sigma.
H2O2, GSH were freshly made and used within 4 hrs. Other regents were prepared in highconcentration stocks in double-distilled water or dimethyl sulfoxide (DMSO). In cases where
DMSO was used, the final concentration of DMSO in solution was less than 0.1% and this
concentration of DMSO did not have any detectable effect on the channel activity.
4.2 Mesenteric artery preparation and tension measurement.
All animal experiments were performed in compliance with an approved protocol by the
Institutional Animal Care and Use Committees (IACUC) at Georgia State University. Male
Sprague-Dawley rats (200-250g body weight) were deeply anesthetized and sacrificed.
Mesenteric arteries were dissected and the connective tissues were removed in PSS containing
(in mM): NaCl 140, KCl 4.6, CaCl2 1.5 MgCl2 1, glucose 10, HEPES 5, pH 7.3. The arteries
were cut into small rings (2 mm in length) and transferred to ice-cold Krebs solution containing:
NaCl 118.0, NaHCO3 25.0, KCl 3.6, MgSO4 1.2, KH2PO4 1.2, glucose 11.0, CaCl2 2.5. The
arterial ring was mounted on a force-electricity transducer (Model FT-302, iWorx/CBSciences,
Inc. Dover, NH) for measurements of isometric force contraction in a 5-ml tissue bath filled with
the air bubbled Krebs solution. All rings were pre-tested with phenylephrine (PE) to ensure the
tissue vitality. When endothelium-free rings were needed, the rings were rubbed with a sanded
polyethylene tubing. The endothelium-free rings were then tested for PE contraction followed by
acetylcholine (Ach, 1 µM). The rings were considered to be endothelium-free if more than 90%
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relaxation was eliminated. PE and ACh were then washed out, and the rings were allowed to
equilibrate in the Krebs solution for another 30-60 min before the experiments (Yang et al.,
2010; Yang et al., 2008).
4.3 Expression of KATP channel in HEK293 cells.
All wild-type and mutant channels were expressed in HEK293 cells because these cells
have minimum endogenous KATP channels. The HEK293 cells were cultured in DMEM/F12
medium with 10% fetal bovine serum and Penicillin/streptomycin at 37 °C with 5% CO2. A
eukaryotic expression vector pcDNA3.1 was used to express rat Kir6.1 (GenBank No. D42145)
or mouse Kir6.2 (GenBenk No. D50581) in the cells with SUR2B (GenBank No. D86038,
mRNA isoform NM_011511). A 35 mm petri dish of cells was transfected with 1 µg Kir6.1 or
Kir6.2 and 3 µg SUR2B using Lipofectamine2000 (Invitrogen Inc., Carlsbad, CA). To facilitate
the identification of positively transfected cells, 0.4 µg green fluorescent protein (GFP) cDNA
(pEGFP-N2, Clontech, Palo Alto, CA) was included in the cDNA mixture. One day after
transfection, cells were disassociated with 0.25% trypsin, split and transferred to cover slips for
further growth. Experiments were performed on the cells in cover slips during the following 1248 hrs (Shi et al., 2007a; Shi et al., 2008a; Yang et al., 2010).
4.4 Electrophysiology.
Patch clamp experiments were carried out at room temperature as described previously
(Shi et al., 2007a; Shi et al., 2010; Shi et al., 2008a; Shi et al., 2008b; Shi et al., 2007b; Yang et
al., 2008). In brief, fire-polished patch pipettes with 2-5 M resistance were made from 1.2 mm
borosilicate glass capillaries. Whole-cell currents were recorded in single-cell voltage clamp with
holding potential 0 mV and step to – 80 mM. The bath solution contained (in mM): KCl 10,
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potassium gluconate 135, EGTA 5, glucose 5, and HEPES 10 (pH=7.4). The pipette was filled
with a solution containing: KCl 10, potassium gluconate 133, EGTA 5, glucose 5, K2ATP 1,
NaADP 0.5, MgCl2 1, and HEPES 10 (pH=7.4). To avoid nucleotide degradation, all
intracellular solutions were freshly made and used within 4 hrs. All the recordings were made
with the Axopatch 200B amplifier (Axon Instruments Inc., Foster City, CA). The data were lowpass filtered (2 kHz, Bessel 4-pole filter, -3 dB), and digitized (10 kHz, 16-bit resolution) with
Clampex 9 (Axon Instruments Inc.). Macroscopic currents were recorded from giant inside-out
patches, and single-channel currents were recorded from small inside-out patches with a constant
single voltage of – 80 or – 60 mV. Symmetric high K+ (145 mM in total) was used in both bath
and pipette solution and K2ATP 1 mM and NaADP 0.5 mM was included in the bath solution to
maintain the channel activity. Higher sampling rate (20 kHz) was used to digitize the currents
recorded from inside-out patch. Data was analyzed using Clampfit 9 (Axon Instruments Inc.).
4.5 Immunochemistry.
Immunochemistry was performed on the HEK293 cells with or without Kir6.1/SUR2B
transfection. Two hours before the experiments, the culture medium was replaced with fresh one.
Biotinylated glutathione ethyl ester (BioGEE, 250 µM, Invitrogen) was added to the medium and
incubated for 1 hr followed by H2O2 (750 µM) challenge for 15 min. The medium was then
discarded and the cells were washed 3 times with PBS (containing 0.3% Triton X-100) to
remove the excessive free BioGEE that was not conjugated with proteins. Cells were then fixed
with 4% paraformaldehyde for 30 min followed by 3 times of washing using PBS. Dylight-488
conjugated streptavidin was diluted in 1:1000 in PBS and added to the cells for 1 hr incubation at
room temperature. After three washes, the cells were examined under regular or confocal
microscopes. For double staining, the cells were further incubated with rabbit primary antibody
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against Kir6.1 for 2 hrs followed by 3 washes. Dylight-594 conjugated goat anti-rabbit secondary
antibody (1:1000, Jackson ImmunoResearch) was used to visualize the Kir6.1 staining.
Experiments were repeated three times (Yang et al., 2010).
4.6 Streptavidin pull-down assay and western blot.
HEK293 cells expressing Kir6.1/SUR2B channels and the A10 smooth muscle cell line
were used for the experiment. A10 cells were cultured in DMEM with 10% fetal bovine serum
(FBS) at 37 °C in humidified atmosphere with 5% CO2. BioGEE and H2O2 treatments were
performed as described in Immunochemistry. Cells were then washed once and lyzed using RIPA
buffer (Sigma). Samples were run on 10% SDS-polyacrylamide non-reducing gel and then
transferred to a nitrocellulose membrane (Bio-Rad). Rabbit primary antibodies against Kir6.1
(1:500, Sigma) and secondary antibodies conjugated with alkaline phosphatase were used in the
Western blot (1:10,000, Jackson ImmunoResearch). Signals were visualized by SuperSignal
West Pico Chemiluminescent Substrate (Thermo Scientific).
Biotin-GSH conjugated proteins were pulled down using streptavidin-dynabeads
according to the instruction of the provider (Invitrogen). Briefly, the beads were washed three
times before the immobilization. Samples were then mixed with beads and incubated at room
temperature with gentle rotation for 30 min. A magnet was used to separate the biotinylated
molecules-beads complex with other unlabeled proteins. Supernatant containing unlabeled
proteins was discarded and the pellet was resuspended followed by three washes. The
biotinylated molecules-beads complex were then resuspended in the loading buffer with 0.1%
SDS and boiled so that the glutathionylated proteins were released into solvent for further
analysis. Experiments on HEK293 cells transfected with Kir6.1/SUR2B channel were repeated
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four times and experiments on A10 cells were repeated five times (Yang et al., 2011; Yang et al.,
2010).
4.7 Mutagenesis and chimeras construction.
Kir6.x channels were divided into 3 regions (N-terminus, core domain containing two
transmembrane domains and the pore loop, and C- terminus). For Kir6.1, N terminus, core, and
C terminus was referred to as residues 1-71, 72-186 and 187-424, respectively. For Kir6.2,
corresponding domain was 1-70, 71-176, and 177-390, respectively. Kir6.1-Kir6.2 chimeras
were created by overlap extension using PCR reaction using pfu DNA polymerase (Stratagene,
La Jolla, CA). WT Kir6.1 was called 111. If the N- terminus was replaced by the corresponding
regions from Kir6.2, we called it 211. Similarly, if the C-terminus of Kir6.1 was constructed to
Kir6.2, we designated the chimerical channel 221. All the other possible combinations were also
created and were named after this naming system. Site-directed mutagenesis kits (Stratagene)
were used to introduce mutations. In these experiments, two oligonucleotide primers (30-35 bp)
will be synthesized, each of which contains the same mutation and anneals to the same sequence
on opposite strands of the cDNA. Pfu DNA polymerase was used to extend and incorporate the
mutagenic primers leading to two nicked circular strands. DpnI was used to digest the
nonmutated parental cDNA and the circular, nicked dsDNA was transformed to XL1-Blue
supercompetent cells. The correct constructs and mutations were confirmed by sequencing (Shi
et al., 2008a; Yang et al., 2011).
4.8 Structural modeling.
The native Kir6.1 structure was generated by I-TASSER protein structure prediction (Wu
et al., 2007; Zhang, 2007, 2008) based on the most recent crystal structure of eukaryotic Kir2.2
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(PDB entry: 3jyc) (Tao et al., 2009) and bacterial KirBac1.1 (PDB entry: 1p7b), KirBac3.1 (PDB
entry: 1xl4) and prokaryotic Kir3.1 channel chimera (PDB entry: 2qks) as the templates(Kuo et
al., 2003; Nishida et al., 2007). The Kir6.1 open state structure was generated using the
KirBac1.1 open state model provided by Dr. Venien-Bryan (Kuo et al., 2005). The native Kir6.1
structural model was further modified by incorporating the GSH molecule onto the thiol group of
Cys176. The potential locations and orientations of GSH in Kir6.1 structural model were
determined using energy minimization by AMMP (Harrison and Weber, 1994) based on the
interaction of charged groups of GSH with charged amino acid groups of Kir6.1 proteins. The
one with lowest biding energy between GSH and the Kir6.1 protein was chosen for further
analysis and presentation. Distances between molecules were measured with PyMol. The
sequence alignment was generated by ClustalW2. Structural images were generated with PyMol
molecular graphics system (Yang et al., 2011).
4.9 Acute dissociation of mesenteric vascular smooth cells.
Single vascular smooth cells were prepared with two-step enzyme digestions. Main
branch of mesenteric arteries were obtained as mentioned above. After clearance of connective
tissue, 1-2 mm small segments were cut and placed in 5ml solution containing (in mM): NaCl
140, KCl 5.4, MgCl2 1, CaCl2 0.1, HEPES 10 and

D-glucose 10 for 10 min in room

temperature. The tissues were then placed in 1ml of the same solution with 20 U of papain
(Worthington, New Jersey), 1.25 mg DTT and 1% fetal bovine serum. After 25min digestion at
35°C, the tissues were washed and incubated with 440 U collagenase (CLS II, Worthington),
1.25 mg trypsin inhibitor (Sigma) and 1% fetal bovine serum for 10 min. After thorough washes,
the tissues were triturated with a fire-polished Pasteur pipette to yield single cells. The
dissociated smooth muscle cells were placed in a petri dish and allowed to attach to the dish
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surface before recordings. Patch clamp experiments were carried out in the cells that show clear
smooth muscle morphology, and had no sign of swelling and shrinkage (Shi et al., 2007a; Shi et
al., 2008a; Yang et al., 2008).
4.10 Data analysis.
Data were presented as means ± standard error (s.e.). Differences were tested by
Student’s t test or analysis of variance (ANOVA). Significant differences were accepted when P
was < 0.05.
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5.1 Abstract:
The KATP channel is an important player in vascular tone regulation. Its opening and
closure lead to vasodilation and vasoconstriction, respectively. Such functions may be disrupted
in oxidative stress seen in a variety of cardiovascular diseases, while the underlying mechanism
remains unclear. Here, we demonstrated that S-glutathionylation was a modulation mechanism
underlying oxidant-mediated vascular KATP channel regulation. An exposure of isolated
mesenteric rings to H2O2 impaired the KATP channel-mediated vascular dilation. In whole-cell
recordings and inside-out patches, H2O2 or diamide caused a strong inhibition of the vascular
KATP channel (Kir6.1/SUR2B) in the presence, but not in the absence, of GSH. Similar channel
inhibition was seen with GSSG and thiol-modulating reagents. The oxidant-mediated channel
inhibition was reversed by the reducing agent DTT and the specific deglutathionylation reagent
glutaredoxin-1 (Grx1). Consistent with S-glutathionylation, pull-down assays with BioGEE
showed incorporation of GSH to the Kir6.1 subunit in the presence of H2O2. These results
suggest that S-glutathionylation is an important mechanism for the vascular KATP channel
modulation in oxidative stress.
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5.2 Introduction:
KATP channels are regulated by intracellular ATP/ADP and couple intermediary
metabolic states to membrane excitability. The activity of these channels is low under
physiological conditions and drastically rises during metabolic stress (Miki and Seino, 2005).
The KATP channels are expressed in almost all tissues. In SMCs, activation of KATP channels by
several vasodilators reduces SMC membrane excitability, leading to vasorelaxation (Shi et al.,
2007b; Yang et al., 2008). Activity of the channels is inhibited by vasoconstrictors (Shi et al.,
2007a), resulting in depolarization of the SMCs and vasoconstriction. Such a common vascular
regulator is thus targeted by a variety of cellular events in physiological and pathological
conditions (Miki and Seino, 2005; Teramoto, 2006).
One important cellular event is oxidative stress that is known to play an important role in
the development and maintenance of several cardiovascular diseases, such as hypertension,
atherosclerosis, and diabetic vascular complications (Brownlee, 2001; Madamanchi et al., 2005).
During oxidative stress, excessive reactive oxygen species (ROS), such as superoxide, hydroxyl
radicals, and H2O2, are overly produced causing vascular dysfunction and structural damages
(Ardanaz and Pagano, 2006; Gutterman et al., 2005). Previous studies indeed have shown that
O2‾ suppresses KATP channels and blunts the pial arterial dilation responses (Armstead, 1999). In
diabetic patients, in whom oxidative stress is evident, KATP channel function is disrupted, leading
to impaired vasodilation responses (Miura et al., 2003). In insulin-resistant rats, the KATP
channel-dependent vasodilation is also impaired, which is likely to be mediated by ROS (Erdos
et al., 2004). Although the dysfunction of KATP channels in oxidative stress has been documented,
the mechanism underlying channel modulation remains unknown (Gutterman et al., 2005;
Weintraub, 2003).
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ROS can modulate proteins by intra- and intermolecular thiol oxidation (Moran et al.,
2001), which may be the underlying cause for the modulation of vascular KATP channels in
oxidative stress. To test this hypothesis, we performed studies using a combined molecular
biology, electrophysiology, and biochemistry approach. Our results showed that the
Kir6.1/SUR2B channel, the major isoform of vascular KATP channels, was inhibited by
micromolar concentrations of H2O2 as well as several other oxidants via S-glutathionylation.
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5.3 Results
5.3.1 H2O2 impaired pinacidil-induced vasodilation in isolated mesenteric rings.
In order to define conditions whereby oxidative stress disrupts vascular K ATP channel
function, we examined the vasodilating effects of the KATP channel opener in the presence and
absence of H2O2. Experiments were conducted on endothelium-intact (EI) and endotheliumdenuded (ED) mesenteric rings. Vasoconstriction was first produced with 30 mM K+ in ED
rings. This was followed by treatments with increasing concentrations of pinacidil, a specific
KATP channel opener and a strong vasodilator (Fig. 5-1A). The vascular tones were measured
with a force-electricity transducer. A pre-treatment of the rings with H2O2 (300, 600 µM)
impaired the pinacidil-induced vasodilation in both ED and EI rings. In ED rings, the IC50
concentration of pinacidil for vasorelaxation was raised by 5–18 folds with the 300 µM and 600
µM H2O2 treatments, respectively (Fig. 5-1A, B). Similar results were obtained in EI rings (Fig.
5-1C). Taken together, our data indicate that the function of vascular KATP channels is disrupted
in oxidative stress.
5.3.2 H2O2 inhibited Kir6.1/SUR2B channel activity in the presence of GSH.
The Kir6.1/SUR2B channel is the major isoform of vascular KATP channels (Cao et al.,
2002; Teramoto, 2006; Tricarico et al., 2006). Thus, we studied its modulation by expressing the
Kir6.1/SUR2B channel in HEK293 cells. In whole-cell voltage clamp, the baseline
Kir6.1/SUR2B currents were small, and no obvious effect on the currents was observed when
H2O2 was applied. After the currents were activated by pinacidil, however, the Kir6.1/ SUR2B
channel was dose-dependently inhibited by H2O2 with an IC50 of 1.53 mM (Fig. 5-2A, E, F).
The results of whole-cell recordings may be affected by washout or inadequate controls
of cytosolic soluble factors that can be potentially involved in the channel modulation, such as
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endogenous GSH and GSSG. Therefore, further studies were performed in excised patches. In
giant inside-out patches, millimolar concentrations of H2O2 were required to inhibit the
Kir6.1/SUR2B channel in the absence of cytosolic soluble components (Fig. 5-2B, E, F).
Strikingly, the administration of small amount of GSH drastically enhanced the channel
sensitivity to H2O2. In the presence of 100 µM of GSH, H2O2 as low as 10 µM began to inhibit
channel activity, and clear concentration dependence was seen with an IC50 of 25 µM (Fig. 5-2C,
E, F). The effect of H2O2 was subsequently studied in the presence of 2 mM GSH and 40 µM
GSSG, a ratio that is close to the physiological concentrations of GSH/GSSG in the cytosol
(Waypa et al., 2006). Under this condition, H2O2 also potently inhibited the channel with an IC50
of 20 µM (Fig. 5-2D-F).
Consistent with these observations in inside-out patches, a supplement of GSH/GSSG (2
mM and 40 µM, respectively) to the pipette solution significantly enhanced the channel
sensitivity to H2O2 in whole-cell recordings. With 100 µM H2O2, the whole-cell currents were
inhibited by 36.2± 8.8% (n = 5) instead of by 8.0± 5.1% (n = 4) without these substances in the
pipette (p < 0.05, Fig. 5-2G). In comparison, the same concentration of H2O2 (100 µM) inhibited
the channel by >80% in inside-out patches in the presence of GSH or GSH/GSSG (Fig. 5-2G).
The difference in the H2O2 sensitivity between inside-out patches and whole-cell recordings may
be due to the diffusion kinetics across plasma membranes. Using the pseudo-first-order reaction
analysis described by Tang et al. in their study on H2O2-mediated BK channel inhibition (Tang et
al., 2004), we calculated the pseudo first order constant (724 M-1 min-1) on the basis of the
average Kir6.1/SUR2B channel inhibition (36.2%) by 100 µM H2O2 in a period of <5 min. With
the rate constant, our further calculation showed that a 50% inhibition of the channel was
achieved by ~23 µM H2O2 in ~30 min. The requirement of GSH for H2O2 to produce its channel
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inhibition effect indicates that GSH-mediated protein modifications of the Kir6.1/SUR2B
channel, such as S-glutathionylation, are likely to occur when H2O2 is produced as an
intermediary metabolite or a product of oxidative stress.
To understand the biophysical mechanisms underlying Kir6.1/SUR2B modulation, we
analyzed single channel properties recorded in regular inside-out patches in the presence of 2
mM GSH and 40 µM GSSG. We found that the channel open-state probability was progressively
suppressed with increased H2O2 concentrations while the unitary conductance remained
unchanged (Fig. 5-2D).
5.3.3 GSH-dependent modulation by other oxidants.
Diamide, an oxidant that produces intra- and intermolecular disulfide bonds, is known to
cause S-glutathionylation in the presence of GSH (Kil et al., 2008; Wang et al., 2005). In giant
inside-out patches, we found that the joint application of diamide and GSH drastically inhibited
channel activity within 2–8 min, regardless of the order of application, i.e., 78.4 ± 5.1%
inhibition with GSH first and 87.9 ± 8.7% inhibition with diamide first (Fig. 5-3A, B, E). No
statistical difference was found between the experiments (P > 0.05, n = 12). In contrast, neither
GSH (Fig. 5-3C, E) nor diamide alone (Fig. 5-3D, E) resulted in such channel inhibition over an
extended time period (8~14 min), suggesting that the channel inhibition is unlikely to be a result
of the formation of disulfide bonds within a protein or between proteins.
GSSG is another S-glutathionylation inducer (Kil et al., 2008; Wang et al., 2005). In
giant inside-out patches, we found that the application of GSSG inhibited the Kir6.1/SUR2B
channel in a concentration-dependent manner (Fig. 5-4A, B). Evident channel inhibition was
seen with 0.5 mM GSSG, and stronger inhibition was produced by higher concentrations (Fig. 5-
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4A, B). Together, these data strongly suggest that S-glutathionylation appears to occur in the
Kir6.1/SUR2B channel during oxidative stress leading to the inhibition of the channel activity.
5.3.4 Thiol oxidants inhibited the Kir6.1/SUR2B channel.
Several reactive 2-pyridinedisulfides (2-PDSs; Fig. 5-5A, C) are known to target the free
sulfhydryl groups of cysteine residues forming thiol moieties, a protein modulation mechanism
that resembles S-glutathionylation (Yoshida et al., 2006). Thus, we further tested the thiol
oxidation of the Kir6.1/SUR2B channel using several 2-PDSs. In whole-cell recording, the bath
application of 2, 2’-dithiodipyridine (2-DTP; 50 µM), a membrane permeable 2-PDS, inhibited
the Kir6.1/SUR2B currents almost completely (by 95.8± 1.1%; n = 5; Fig. 5-5D, E). Similar
results were obtained with another membrane permeable 2-PDS, 2, 2’-dithiobis-5-nitropyridine
(DTNP; 50 µM), which inhibited the currents by 88.8± 2.7% (n = 5; Fig. 5-5B, E). These
observations are also consistent with S-glutathionylation.
5.3.5 Reversal of the KATP channel inhibition by deglutathionylation reagents.
After pinacidil-activated currents were strongly inhibited by the oxidants, washout with
addition of pinacidil (10 µM) had only a modest effect on channel activity (10.2 ± 2.6% of the
original pinacidil-induced currents; n = 4; Fig. 5-2C). Increasing the pinacidil concentration to
100 M had no additional effect (3.9 ± 0.6% of the original pinacidil induced-current, n = 3; Fig.
5-3A). However, application of the reducing agent DTT (5 mM) reversed the GSSG-mediated (5
mM) current inhibition by 36.1± 4.7% (P < 0.001; n = 4; Fig. 5-4C, E). Similarly, the 2-PDS
mediated channel inhibition was partially reversed by DTT by 34.9± 10.3% (n = 5; Fig. 5-5D,
E).
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An exposure of the cell to the specific deglutathionylation reagent glutaredoxin-1 (Grx1;
4 µM) immediately reversed current inhibition by 27.8±10.5% (P < 0.05; n = 4). After washout
of both GSSG and Grx1, the pinacidil-induced currents were resumed to 72.0±7.1% of its
original level (P < 0.001; n = 4; Fig. 5-4D, F). Collectively, these data suggest that Sglutathionylation-mediated Kir6.1/SUR2B channel inhibition can be reversed substantially by
deglutathionylation reagents.
5.3.6 Biochemical evidence for the Kir6.1 S-glutathionylation.
Does S-glutathionylation occur on the channel protein or on another protein that regulates
the channel activity? To address this question, we examined S-glutathionylation using
membrane-permeable BioGEE. HEK293 cells transfected with Kir6.1/SUR2B or the expression
vector alone were loaded with BioGEE (250 µM) for 1 hr followed by an H2O2 (750 µM)
challenge for 15 min. Clear labeling was observed in the Kir6.1/SUR2B-transfected cells (Fig. 56A-C), whereas a rather weak stain was seen with the mock transfection (data not shown). When
the cells were double-stained with BioGEE (green) and Kir6.1 antibodies (red), co-localization
was observed (Fig. 5-6D–F).
The Kir6.1 S-glutathionylation was further tested with the streptavidin pull-down assay
(Zmijewski et al., 2009). The A10 vascular smooth muscle cell line, in which the Kir6.1/SUR2B
channel was endogenously expressed (Shi et al., 2010; Sun et al., 2004), was loaded with
BioGEE (250 µM) for 1 hr followed by an H2O2 (750 µM) challenge for 15 min. A strong
Kir6.1-reactive band (~32 kDa) was detected in the whole-cell lysate (Fig. 5-6G; lower panel).
After pull-down with streptavidin, the cell lysate pretreated with a combination of BioGEE and
H2O2 showed a clear band of Kir6.1 immunoreactivity (Fig. 5-6G; upper panel), while no band
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was observed in cell lysates treated with either BioGEE or H2O2 alone (Fig. 5-6G). Similar
results were obtained using HEK293 cells transfected with Kir6.1/SUR2B.
5.3.7 Inhibition of the KATP channel activation by natural activators.
Kir6.1/SUR2B channel activity is low under basal condition but increases significantly in
the presence of several vasodilating hormones and neurotransmitters that are coupled to the
adenylyl cyclase-cAMP-PKA pathway (Shi et al., 2008a; Shi et al., 2007b). Therefore, we
examined the effect of S-glutathionylation on the Kir6.1/SUR2B currents activated by VIP (100
nM) and β-adrenoceptor agonist isoproterenol (Isop; 100 nM), both of which activate
Kir6.1/SUR2B currents through the PKA pathway. In the whole-cell configuration, DTNP (50
µM) or 2-DTP (50 µM) inhibited Isop-activated currents strongly (94.1 ± 3 .6% and 97.0± 0.9%,
respectively; n = 4; Fig. 5-7A, C). Similarly, 2-DTP inhibited the VIP-activated currents by
89.7± 1.4% (n = 3; Fig. 5-7C). 2-DTP and DTNP were not acting at the level of the receptors as
forskolin, an adenylyl cyclase activator, elicited currents that were also potently inhibited by
these agents (Fig. 5-7C). In inside-out patches, basal currents as well as the currents activated by
the catalytic subunit of PKA (cPKA; 50 units/mL), were strongly inhibited by 5 mM GSSG as
well (79.1± 5.4%, n = 4 and 89.1± 5.0%, n = 4, respectively; Fig. 5-7B, C). Taken together, these
results indicate that the Kir6.1/SUR2B channels are inhibited by S-glutathionylation, regardless
of how the channels are activated.
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5.4 Discussion
Inflammatory oxidative stress is a common pathogenesis of cardiovascular diseases,
including hypertension, atherosclerosis, and diabetic vascular complications, which mostly result
from the overproduction of ROS overwhelming the capacity of cellular antioxidant defense
systems (Brownlee, 2001; Madamanchi et al., 2005). When excessively produced, ROS can
cause damages to lipids, proteins, and nucleotides, leading to cell dysfunction, structural injuries,
and death (Madamanchi et al., 2005). As the universal antioxidant treatment did not yield
promising results in clinic trials (Kris-Etherton et al., 2004), the identification of specific
molecules and the understanding of the molecular mechanisms underlying the oxidant-mediated
protein modulation became crucial for the development of novel therapeutic strategies. Our
studies indicate that the Kir6.1/SUR2B channel is inhibited by micromolar concentrations of
H2O2 through S-glutathionylation. Such channel inhibition is of pathophysiological relevance and
is likely to occur in vasculatures as the production of micromolar concentrations of H2O2 has
been shown during oxidative stress (Ardanaz and Pagano, 2006).
H2O2, O2˙─, and ˙OH are the major oxidants produced endogenously in biological
systems. Their concentrations in the cytoplasm are tightly controlled by several antioxidant
systems (Pryor et al., 2006). Early studies have shown that ROS including H2O2 have
modulatory effects on membrane proteins (Liu and Gutterman, 2002b; Tang et al., 2004; Zha et
al., 2009). Most of the studies, however, use millimolar concentrations of H2O2 (Ichinari et al.,
1996; Krippeit-Drews et al., 1999). In the present study, we have observed a clear inhibition of
the Kir6.1/SUR2B channel by H2O2 with IC50 of ~1.5 mM in whole-cell recording. In contrast,
the inhibition of KATP currents can be clearly seen with micromolar concentrations of H2O2 in
vascular rings. The major reason for the discrepancy is likely to be the effect of washout or
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inadequate controls of the cytosolic soluble factors that play a role in the channel modulation in
oxidative stress. Indeed, some of the cytosolic substances are identified to be GSH and GSSG in
the present study.
Searching for the missing cytosolic factors to better characterize the effect of H2O2, we
conducted experiments in giant inside-out patches. We have found that supplying a small amount
of exogenous GSH dramatically reduces the concentration of H2O2 needed for channel inhibition.
Using 2 mM GSH and 40 µM GSSG, which mimic the intracellular GSH/GSSG ratio (Brown et
al., 2007; Waypa et al., 2006), we have also observed clear channel inhibition by micromolar
concentration of H2O2. The drastic effect of GSH/GSSG on the channel sensitivity to H2O2 is not
only seen in inside-out patches, but also takes place in the whole-cell recordings. A supplement
of GSH/GSSG to the pipette solution markedly augments the H2O2-mediated inhibition of the
whole-cell Kir6.1/SUR2B currents.
Comparing the inside-out patch data with the whole-cell recordings, we have found that
the lower H2O2 sensitivity in the whole-cell recordings appears to be also related to the
transmembrane diffusion kinetics. The limited capacity of transmembrane diffusion may act as a
cellular protection mechanism, diminishing or even eliminating the effect of a burst of H 2O2
production in the interstitial fluid. In the vascular inflammation state, however, such a membrane
barrier does not seem adequate to protect the cell against a long-lasting production of H2O2.
Consequently, H2O2 manages to pass through the plasma membranes and inhibits the channel
from inside with a potency similar to that seen in inside-out patches.
Such channel inhibition is not limited to H2O2 as diamide, another oxidant, also produces
strong channel inhibition when applied together with GSH. Furthermore, channel inhibition can
be produced by the general S-glutathionylation-inducer GSSG. These results thus indicate that S-
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glutathionylation is likely to be the underlying cause for Kir6.1/SUR2B channel inhibition by
these oxidants under pathophysiological conditions.
Hence, several lines of evidence shown in the present study support S-glutathionylation
of the Kir6.1/SUR2B channel. (i) The channel is inhibited by H2O2 or diamide potently only
when there is GSH. (ii) The S-glutathionylation inducer GSSG causes the channel inhibition. (iii)
Several 2-PDSs react with thiol groups to form adaptors at cysteine residues to inhibit the
Kir6.1/SUR2B channel in micromolar concentrations. (iv) The oxidant-mediated channel
inhibition can be reversed by the specific deglutathionylation reagent Grx1 and the general
reducing reagent DTT. (v) Our pull-down assays reveal the incorporation of the GSH moiety to
the Kir6.1 subunit in the presence but not in the absence of H2O2. This KATP channel modulation
mechanism is not limited to the pinacidil-induced currents. The KATP currents activated by the
natural vasodilators VIP and Isop are similarly inhibited by these oxidants.
The modulation of protein activity by S-glutathionylation is a newly recognized posttranslational regulatory mechanism (Dalle-Donne et al., 2008; Dalle-Donne et al., 2009). This
process, facilitated by oxidative stress and also seen in unstressed cells, can result in major
changes to protein conformations and functions. Such modulation has been demonstrated in a
large number of proteins using microarray (Fratelli et al., 2005) or proteomic analysis (Lind et
al., 2002), while the physiological relevance of this modulation remains to be understood (DalleDonne et al., 2008). Several recent studies indicate that the following membrane proteins are
modulated by S-glutathionylation: the cystic fibrosis transmembrane conductance regulator
(Wang et al., 2005), the ryanodine receptor (Aracena-Parks et al., 2006), the sarco/endoplasmic
reticulum Ca++ ATPase (Adachi et al., 2004), and the Na+-K+ pump (Figtree et al., 2009). The
present study has shown for the first time that an important vascular tone regulator,
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Kir6.1/SUR2B channel, is subject to S-glutathionylation that can be produced with H2O2 at
physiological or pathophysiological concentrations. This channel modulation by H2O2 can lead
to impairment of the vasodilation responses in a variety of vascular complications. Therefore, the
demonstration of S-glutathionylation as a regulatory mechanism has important clinical
implications. With the information, new therapeutic strategies may be formulated by preventing
the oxidative modulation of the Kir6.1/SUR2B channel.
Another similar post-translational regulation mechanism is S-nitrosylation through which
a nitric oxide (NO) moiety is incorporated into the thiol group of a cysteine residue (MartinezRuiz and Lamas, 2007; Yoshida et al., 2006). However, our initial attempts using NO donors
yielded inconsistent results (data not shown).
In conclusion, our studies indicate that the Kir6.1/SUR2B channel is inhibited by H2O2 at
micromolar concentrations owing to S-glutathionylation in the Kir6.1 subunit. The
demonstration of the mechanism underlying the impairment of the vascular KATP channel should
have impacts on the treatment and prevention of several vascular diseases caused by oxidative
stress.
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Figure 5-1. The responses of mesenteric rings to KATP channel opener. A, the relaxing effect
of the KATP channel opener pinacidil (Pin) with and without H2O2 pre-treatment were studied in a
vascular endothelium-denuded (ED) ring obtained from mesenteric artery. The ring was
contracted with 30 mM K+ followed by increasing concentrations of Pin. The constriction force
was measured using a force-electricity transducer. Under basal conditions, Pin effectively
relaxed the ring with a midpoint effect of ~10 µM. K+ and Pin were then washed out. After
equilibration for 30 min, 300 µM H2O2 was applied to the ring for 10 min, and the ring was
constricted again using K+ followed by incremental concentrations of Pin. In this condition, the
relaxing effect of Pin was impaired. About a 10-fold higher concentration of Pin was needed to
relax the ring to the same 50% level. This experiment was then performed again with another
dose of H2O2 (600 µM) pretreatment followed by a final control round in which >80% recovery
in both constriction and relaxation was seen. B, in ED rings, the concentration-dependent
vasodilation of Pin is shown in the presence and absence of H2O2. The data were described by
the Hill equations with IC50 of 15 µM in control (n = 11), 70 µM with 300 µM H2O2 pretreatment
(n = 4), and 280 µM with 600 µM H2O2 pretreatment (n = 7), respectively. C, similar
experiments were also done in endothelium-intact (EI) rings with IC50 16 µM in control (n = 6),
100 µM with 300 µM H2O2 pretreatment (n = 6), and 240 µM with 600 µM H2O2 pretreatment (n
= 5), respectively.
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Figure 5-1
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Figure 5-2. Responses of vascular KATP channel to H2O2. A, whole-cell currents were recorded
from a cell expressing Kir6.1/SUR2B channels. The bath solutions contained 145 mM K+,
making the reversal potential of the K+ currents close to 0 mV. Command pulses of –80 mV
were given every 3 s. The recording pipette was filled with the same solution (bath solution) with
the addition of 1 mM ATP, 0.5 mM ADP, and 1 mM free Mg++. Application of pinacidil (Pin, 10
µM) markedly augmented the whole-cell currents that were subsequently inhibited by 0.3 mM
and 3 mM H2O2 progressively. The KATP channel specific blocker, glibenclamide (Glib; 10 µM)
further reduced channel activity. The lower panel shows individual current traces produced by
single command pulses. B, currents were recorded from giant inside-out patches obtained from
HEK293 cells expressing the Kir6.1/SUR2B channel with a holding potential of –60 mV.
Currents were activated by Pin, followed by increasing doses of H2O2. The H2O2 exposures did
not lead to significant changes in channel activity. C, in the presence of GSH (100 µM), the
H2O2 application strongly inhibited the Pin-activated currents, and the channels were almost
completely inhibited by 100 µM H2O2 in giant inside-out patches. D, similar channel inhibition
by H2O2 occurred in the presence of 2 mM GSH and 40 µM GSSG. Single channel activity is
displayed in expanded records from the top trace. Five active channels were seen, which were
dose-dependently inhibited by H2O2. Note that the channel retained the same conductance with
H2O2 exposure. Labels on the right: C, closure and 1, 2…5, the first, second … fifth opening. E,
dose-response relationships obtained in the whole-cell or inside-out patch configurations with or
without GSH/GSSG. F, the half maximal inhibitory concentration (IC50) of H2O2 was compared
under whole-cell (WC) and inside-out patch (IO) configurations in the absence or presence of
GSH or GSH/GSSG; G, the effect of 100 µM H2O2 on the channel activity showed significant
differences (*, P < 0.05; ***, P < 0.001) between these conditions.
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Figure 5-3. The effect of diamide/GSH on the channel activity. Currents were studied in giant
inside-out patches obtained from HEK293 cells expressing the Kir6.1/SUR2B channel with a
holding potential of –60 mV. A, after channel activation by pinacidil, application of GSH (100
µM) followed by diamide (DIA; 100 µM) for additional ~4 min strongly inhibited the channel
activity. The inhibition was not reversed by high concentration of pinacidil (100 µM). B, in
another cell, the application of DIA followed by GSH also markedly inhibited the Kir6.1/SUR2B
channel activity. C, prolonged GSH (100 µM) treatment did not have detectable effects on the
Pin-activated currents. D, a prolonged treatment (8 min) with DIA (100 µM) did not cause
marked channel inhibition. E, summary of the effects of Pin, GSH alone, DIA alone, GSH
followed by DIA, and DIA followed by GSH.
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Figure 5-4. The effect of GSSG on the channel activity and its reversibility. A, in a cell
expressing the Kir6.1/SUR2B channel, the Pin-activated currents were dose-dependently
inhibited by GSSG treatment. B, summary of different dosages of GSSG on the channel activity
(n = 4~6). C, in a giant inside-out patch, the Pin-induced currents were strongly inhibited by 5
mM GSSG. The current partially recovered with the application of the reducing agent (DTT, 5
mM). D, Pin-induced currents were inhibited by GSSG and partially reversed by 4 µM Grx1.
Additional pinacidil perfusion further augmented the channel activity. E and F, quantification of
the data from A and B, respectively (n = 4). *, P < 0.05; ***, P < 0.001.
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Figure 5-5. Thiol modification by reactive disulfide reagents. A and C, the chemical structures
of 2-DTP and DTNP. B, in whole-cell configuration, the Pin-activated currents were potently
inhibited by DTNP (50 µM). D, another reactive disulfide, 2-DTP (50 µM) also had a strong
inhibitory effect on the Pin-sensitive currents of the Kir6.1/SUR2B channel, and this inhibitory
effect was reversed by the reducing agent DTT (5 mM). E, the effects of 2-DTP (50 µM), DTNP
(50 µM), and DTT (5 mM) on the channel activity are summarized. ***, P < 0.001.
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Figure 5-6. Biochemical detection of the Kir6.1-GSH interaction using BioGEE. A, B and C,
HEK293 cells transfected with Kir6.1/SUR2B were loaded with BioGEE for 1 hr and then
challenged with H2O2 (750 µM) for 15 min. Free, unlabeled BioGEE was washed out, and the
cells were visualized with streptavidin-Dylight 488 under phase contrast (A), florescence
microscopy (B), and overlaid image (C). Labeled and unlabeled cells are indicated by arrows and
asterisks, respectively. D, E, and F, 1.25-m confocal optical slices of HEK293 cells transfected
with Kir6.1/SUR2B were double-stained with Kir6.1 (red) and BioGEE (green). Yellow
indicates that Kir6.1 co-localizes with BioGEE. Scale bar = 25 µm. G, the A10 aortic smooth
muscle cells were lysed with RIPA buffer. Kir6.1 proteins were detected in the whole-cell lysis
(lower panel). Only those protein samples that were obtained from the cells treated with both
H2O2 and BioGEE showed a clear band in the streptavidin pull-down assay (upper panel).
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Figure 5-7. Redox-mediated blockade of the KATP channel activation by natural activators.
A, in whole-cell configuration, isoproterenol (Isop; 100 nM) activated the Kir6.1/SUR2B current
that was subsequently inhibited by DTNP (50 µM). B, in a giant inside-out patch, the channel
was activated by the catalytic subunit of PKA (cPKA; 50 units/mL), and inhibited by 5 mM
GSSG. C, summary of the effects of GSSG, DTNP, and 2-PDS on the Kir6.1/SUR2B channel
induced by a variety of channel activators (n = 3~5). Abbreviations: FSK, forskolin; VIP,
vasoactive intestinal polypeptide. ***, P < 0.001.
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6.1 Abstract:
KATP channel is targeted by a variety of vasoactive substances, playing an important role
in vascular tone regulation. Our recent studies indicate that vascular KATP channel is inhibited in
oxidative stress via S-glutathionylation. Here we show evidence for the molecular basis of the Sglutathionylation and its structural impact on the channel gating. By comparing the oxidant
responses of Kir6.1/SUR2B channel with Kir6.2/SUR2B channel, we found that Kir6.1was the
subunit responsible for oxidant sensitivity. Oxidant screening of Kir6.1-Kir6.2 chimeras
demonstrated that the N-terminus and transmembrane domains of Kir6.1 were crucial.
Systematic mutational analysis revealed three cysteine residues in these domains: Cys43, Cys120
and Cys176. Among them, Cys176 was prominent, contributing to >80% of the oxidant
sensitivity. Kir6.1-C176A/SUR2B mutant channel, however, remained sensitive to both channel
opener and inhibitor, which indicated that Cys176 is not a general gating site in Kir6.1 in
contrast to its counterpart (Cys166) in Kir6.2. Protein pull-down assay with BioGEE showed that
mutation of Cys176 impaired oxidant-induced incorporation of GSH into the Kir6.1 subunit. In
contrast to Cys176, Cys43 had only modest contribution to S-glutathionylation, and Cys120 was
modulated by extracellular oxidants but not intracellular GSSG. Simulation modeling of Kir6.1
S-glutathionylation suggested that after incorporation to residue 176, the GSH moiety occupied a
space between the slide helix and two transmembrane helices. This prevented the inner
transmembrane helix from undergoing conformational changes necessary for channel gating,
retaining the channel in its closed state.
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6.2 Introduction:
KATP channels are expressed in a variety of tissues including smooth muscles, pancreatic
β-cells, myocardium and neurons where they play an important role in cellular function (Nichols,
2006; Yokoshiki et al., 1998). Activity of the KATP channels is tuned by physiological or
pathophysiological stimuli including hypoxia, hyperglycemia, ischemia, and oxidative stress,
allowing a regulation of cellular excitability according to the metabolic state (Miki and Seino,
2005). The vascular smooth muscle (VSM) isoform of KATP channels regulates vascular tones
(Seino, 1999; Teramoto, 2006). Activation of the channel by vasodilators produces
hyperpolarization of VSM cells, reduces activity of the voltage-dependent Ca++ channels, and
relaxes VSMs. Inhibition of the channel leads to constriction of VSMs. Disruption of the
vascular KATP channel in mice results in vasospasm in coronary arteries and sudden cardiac death
(Chutkow et al., 2002; Miki et al., 2002).
Other studies have further shown that disruption of the vascular KATP channel has drastic
effects on the systemic response to septic stress. With a forward genetic approach by genomewide random chemical mutagenesis, Croker et al. (Croker et al., 2007) screened a large
population of mice and found four strains that are highly susceptible to multiple septic pathogens
including lipopolysaccharides (LPS). The LPS hypersensitivity phenotype of these mice is due to
a null allele of Kcnj8, encoding the Kir6.1 subunit of vascular KATP channel (Croker et al., 2007).
Similar septic susceptibility has been observed in Kcnj8-knockout mice that also show coronary
hypoperfusion and myocardial ischemia during LPS exposure. These studies thus indicate that
the vascular KATP channel not only contributes to the vascular tone regulation at physiological
condition, but also affects critically systemic stress responses.
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Our recent studies have shown that the vascular KATP channel is strongly inhibited in
oxidative stress by S-glutathionylation (Yang et al., 2010) . The S-glutathionylation is a posttranslational

modification

mechanism

occurring

in

a

variety

of

physiological

or

pathophysiological conditions. This protein modulation mechanism is remarkable especially in
vasculatures, as oxidative stress is a major contributing factor to several cardiovascular diseases,
in which S-glutathionylation plays an important role (Dalle-Donne et al., 2007). Although Sglutathionylation is often associated with the adverse effects of oxidative stress, such a protein
modulation is reversible under certain circumstances and can act as a functional modulation
mechanism like protein phosphorylation. Thus, demonstration of how the S-glutathionylation
affects protein function should have broad significance. As for the vascular K ATP channel Sglutathionylation, the molecular basis remains unclear. Therefore, we performed the studies to
elucidate the molecular basis and provide structural insight of the K ATP channel Sglutathionylation.
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6.3 Results
6.3.1 Subunit identification
Functional KATP channels consist of four pore-forming Kir6.x subunits (Kir6.1 or Kir6.2)
and four regulatory sulfonylurea receptors (SUR1, SUR2A or SUR2B) (Seino, 1999; Yokoshiki
et al., 1998). The Kir6.1/SUR2B channel is considered to be the major vascular isoform of the
KATP channels, although Kir6.2 is also found in VSM cells (Cao et al., 2002; Tricarico et al.,
2006). Our recent studies demonstrate that Kir6.1/SUR2B isoform of vascular K ATP channel is
targeted by ROS through S-glutathionylation (Yang et al., 2010). To further identify the specific
subunit(s) or isoform(s) targeted by oxidants, we expressed Kir6.1/SUR2B and Kir6.2/SUR2B
channels in HEK cells separately. Both Kir6.1/SUR2B and Kir6.2/SUR2B currents were
activated by the specific KATP channel activator pinacidil (10 µM), and inhibited by the channel
inhibitor glibenclamide (Glib, 10 µM; Fig. 6-1A, B). The currents of interest were normalized to
the window of pinacidil and Glib effects.
Application of H2O2 caused a marked inhibition of the Kir6.1/SUR2B currents in a
concentration-dependent manner (Fig.6-1A, G). In contrast, the Kir6.2/SUR2B currents were
barely inhibited by H2O2 up to 10 mM (4.5±3.3% inhibition, n=4; Fig.6-1B, G). The differential
responses to oxidants between Kir6.1/SUR2B and Kir6.2/SUR2B channels was further
investigated using pyridine disulfides (PDSs), pharmacological tools that react with protein
cysteine residues similarly as S-glutathionylation (Yang et al., 2010). 2,2’-Dithiodipyridine (2DTP, 50 µM), a membrane permeable PDS, inhibited whole-cell Kir6.1/SUR2B currents by
95.8±1.1% (n=5; Fig. 6-1C,H), while the same concentration of 2-DTP inhibited the
Kir6.2/SUR2B channel by only 12.9±0.5% (n=4; Fig. 6-2B). This suggests that the critical
residue(s) or domain(s) for thiol oxidation are located in Kir6.1.
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6.3.2 Intra- versus extracellular location
To determine the intra- vs. extracellular location of the S-glutathionylation sites, the
effects of membrane permeable and impermeable PDSs were compared. Under the same
recording condition as for 2-DTP, a high concentration of 5,5’-dithiobis-2-nitrobenzoic acid
(DTNB, 200 µM), a membrane impermeable PDS, marginally inhibited the channel activity by
28.7±5.2 % (n=5; Fig. 6-1D, H). These different effects of DTNB and 2-DTP were not due to
different potencies of these PDSs, as 2-DTP and DTNB inhibited Kir6.1/SUR2B channel activity
to almost the same extent when they were applied to the internal membranes of inside-out
patches (Fig. 6-1E, F, I). The different effects of 2-DTP and DTNB in whole-cell recording
versus inside-out patches therefore indicate that the modulation of thiol groups takes place
mainly on the intracellular side of the plasma membranes.
6.3.3 Determination of critical protein domains
To determine the critical domains for channel inhibition, we took the advantage of the
different sensitivity of the Kir6.1 and Kir6.2 to thiol oxidation, and performed experiments using
six Kir6.1/Kir6.2 chimerical constructs created in our laboratory (Shi et al., 2008b). In these
chimeras, the N-terminus, transmembrane core region and C-terminus were swapped between
Kir6.1 and Kir6.2. All constructs expressed functional channels with SUR2B. The responses of
these chimerical channels to 2-DTP were then examined. In comparison with 222 (or Kir6.2,
12.9±0.5% inhibition, n=4; Fig. 6-2A, B), chimera 122 (the N-terminus of Kir6.2 was substituted
with that of Kir6.1, and so are named for other chimeras) and 212 gained substantial sensitivity
to 2-DTP with the N-terminus or core domain from Kir6.1 (68.5±6.2% and 57.6±5.9%
inhibition, respectively, n=4, p<0.05; Fig. 6-2A, C, D). However, chimera 221 did not show any
significant difference in its response to 2-DTP compared with 222 (Fig. 6-2A, E, P>0.05).
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Moreover, in comparison with 111 (or Kir6.1, 95.8±1.1% inhibition, n=5), the inhibitory effect
of 2-DTP on both 211 and 121 was significantly reduced (87.4±5.3% and 65.4±8.2% inhibition,
respectively, n=4, p<0.05; Fig. 6-2A). When both the N-terminus and the core domain exist, the
112 had 2-DTP sensitivity (91.9±8.0% inhibition, n=4) as great as the 111 (Fig. 6-2A). This
chimerical analysis thus suggests that both N-terminus and core domain are crucial for the
channel inhibition by 2-DTP.
6.3.4 Cys176 in the Kir6.1 subunit
Systematic mutagenesis was carried out on all cysteine residues of the Kir6.1 (Fig. 6-3A,
B). All the mutants exhibited functional channel activity when expressed with SUR2B in HEK
cells. By 2-DTP screening, we found that one cysteine residue in the core domain (Cys176) and
another in the N-terminus (Cys43) were important, mutations of which disrupted the channel
sensitivity to 2-DTP (50 µM) in whole-cell recordings (Fig. 6-3B-D). Mutation of any other
cysteine residues did not result in significant change in 2-DTP sensitivity using ANOVA
analysis (Fig. 6-3B). Of these two cysteine residues, the Cys176 was more prominent in the
oxidant-mediated channel inhibition, as the Kir6.1-C176A/SUR2B channel lost most of its 2DTP sensitivity (26.0±6.5% inhibition, P<0.001; Fig. 6-2B, C). Consistently, this mutant also
lost its sensitivity to H2O2 (3.5±4.7% inhibition, P<0.001).
The Kir6.1-C176A mutant was further tested with GSSG, an S-glutathionylation inducer
that modulates Kir6.1/SUR2B channel in inside-out patches (Kil et al., 2008; Wang et al., 2005;
Yang et al., 2010). The WT Kir6.1/SUR2B channel was inhibited by GSSG drastically
(84.3±8.7% inhibition, n=5; Fig. 6-4E), while the Kir6.1-C176A/SUR2B channel was rather
resistant to the GSSG treatments (17.8±6.9% inhibition, n=4, P<0.001; Fig. 6-4A, E). A
treatment with 100 µM H2O2 in the presence of 100 µM GSH, another S-glutathionylation
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induction method (Yang et al., 2010), inhibited the Kir6.1-C176A mutant only marginally
(14.7±6.4% inhibition, n=4, P<0.001 compared with Kir6.1 WT; Fig. 6-4B, F) in inside-out
patches. All the results were consistent with the idea that Cys176 was a critical site for Sglutathionylation.
6.3.5 Cys43 and Cys120 in oxidant sensitivity
The Cys43 mutation (C43A) reduced the channel sensitivity to 50 µM 2-DTP
(69.0±3.8% inhibition, n=5; Fig. 6-3B, D), although the effect was significantly smaller than that
of Cys176 (P<0.001). We further tested the effect of GSSG on C43A mutation and found that the
response of the Kir6.1-C43A mutant to GSSG was comparable to its response to 2-DTP,
showing rather modest inhibition of the channel activity (60.9±3.2% inhibition, n=4; Fig. 6-4C,
E). When the Kir6.1-C176A/C43A double mutation channel was tested, we found that the GSSG
effect was completely eliminated (−3.9±3.5% inhibition, n=4; Fig. 6-4D, E)
In addition to Cys176 and Cys43, Cys120 appeared to be important for the channel
sensitivity to extra-cellular oxidants. The Kir6.1-C120S/SUR2B mutant channel lost substantial
2-DTP sensitivity (77.6±5.1% inhibition, n=4; Fig. 6-3E), although statistical significance was
not found using ANOVA analysis. When the data were tested with student’s t-test, however, its
response to 2-DTP was significantly smaller than that of Kir6.1/SUR2B WT channel (P<0.01).
Therefore, further studies were conducted on this site. In inside-out patches, the Kir6.1-Cys120
mutant did not show any reduction in its sensitivity to GSSG in comparison to Kir6.1/SUR2B
WT channel (87.0±5.8% inhibition, n=4 v.s. 84.3±8.7% inhibition, n=5, respectively, P>0.05;
Fig. 6-4E). When this mutant was examined in whole-cell recordings using membrane
impermeable DTNB (200 µM) applied extracellularly, the effect of DTNB was eliminated
almost completely (2.7±6.0% inhibition, n=6; Fig. 6-3F) in comparison to the Kir6.1/SUR2B
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WT channel (28.7±5.2% inhibition by DTNB, n=5; Fig. 6-1D). These data thus suggest that
Cys120 may serve for extracellular redox sensing but does not seem to be an S-glutathionylation
site.
6.3.6 Biochemical evidence for Cys176 modification
As Cys176 was the dominating residue mediating the S-glutathionylation, we performed
additional experiments to validate the essential role of Cys176 in S-glutathionylation
biochemically. HEK cells transfected with WT channels or Kir6.1-C176A/SUR2B mutant were
first tested for the expression of Kir6.1 protein. After cell lysis, anti-Kir6.1 antibodies detected
strong Kir6.1 reactive bands in whole cell extracts in both constructs. According to our previous
study, a strong reactive band of ~32 kDa is Kir6.1-specific (Yang et al., 2010). The specificity of
the antibodies is also confirmed by the internal experiments performed by Sigma-Aldrich. With
β-actin as loading control, we found that the density of Kir6.1-C176A-reactive band was
comparable with Kir6.1 WT band (106±8.5%, n=5), indicating that the C176A mutation did not
change the protein expression pattern of Kir6.1 subunit (Fig. 6-5A). These constructs thus were
subjected to streptavidin pull-down assay. The HEK cells transfected with Kir6.1/SUR2B or
Kir6.1-C176A/SUR2B were incubated with BioGEE (250 µM) for 1 hr followed by 15 min
H2O2 (750 µM) challenge as described previously (Yang et al., 2010; Zmijewski et al., 2009). If
BioGEE was incorporated into the channel proteins, streptavidin-beads then should pull down
the channel-BioGEE complex which would be further detected by Kir6.1 antibodies in western
blot. On the other hand, if the mutation impaired the protein S-glutathionylation, then the
mutation should decrease the binding of Kir6.1 protein to BioGEE, resulting in a weaker or even
no band in western blot. Indeed, we observed different band densities between these two
constructs: After streptavidin pull-down, the density of the Kir6.1-C176A-reactive band was
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much weaker (38.6±3.8%, n=5; Fig. 6-5A, B) compared with the band of Kir6.1 WT channel
after normalizing to protein inputs (Fig. 6-5A, B). The data further demonstrate that the C176A
mutation impaired the Kir6.1 protein S-glutathionylation.
As a control, the washout of the streptavidin bead-protein mixture was also used for
western blot. No clear bands were detected in the washout from samples of either WT or mutant
channels. This indicates that the Kir6.1 protein concentrations in the washout were below the
threshold of detection by western blot.
6.3.7 Simulation modeling
Several Kir channel protein crystal structures including eukaryotic Kir2.2 channel
structure were resolved recently. While N and C-termini show notable variation among different
Kir channels, the core domains are rather conservative. To gain a structural insight into how the
S-glutathionylation of Cys176 affects the channel activity, we modeled the Kir6.1 structure with
a GSH moiety bound at residue 176 in its closed state (Fig. 6-6A, C-G). Our model showed that
after incorporation, the GSH moiety occupied the space between the M0, M1 and M2 helices
(Fig. 6-6C-G). Because the channel opening requires a movement of the M2 inner helix (Kuo et
al., 2005; Kuo et al., 2003), the addition of GSH at residue Cys176 prevented the M2 inner helix
from undergoing such a necessary movement for channel opening. To further validate this idea,
we also modeled Kir6.1 structure in its open state (Fig. 6-6B, H) and compared it with Kir6.1
model in its closed state. In the Kir6.1 open state model, the M2 inner helix was bent and
twisted, making the Cys176 residue facing the M1 outer helix directly (Fig. 6-6H). After energy
minimization, the distance between Cys176 and the closest residue (Leu73) on the M1 outer
helix was 2.8Å (Fig. 6-6H). When there was a GSH moiety on Cys176, channel open state with
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such a short distance between Cys176 and Leu73 could not be achieved. Consequently, the
channel was retained in its closed state.
6.4 Discussion
S-glutathionylation is a post-translational modulation mechanism that involves in a
variety of physiological or pathophysiological events. We have recently shown that the VSM
KATP channel, a vascular tone regulator, is modulated by S-glutathionylation. Our data in the
present study reveal that the Kir6.1/SUR2B channel modulation by S-glutathionylation is likely
to take place primarily at the Cys176 residue of the Kir6.1 subunit. Because of its critical
location, the incorporation of GSH moiety to the Cys176 prevents the pore-forming inner helices
from undergoing necessary conformational change for opening and retains the channel in its
closed state.
Excessive ROS produced during oxidative stress can result in structural modification of
proteins affecting protein function (Dalle-Donne et al., 2007). Although some studies have
shown that the KATP channels are targeted by redox regulation, data are rather inconsistent
regarding the effect of oxidants or thiol oxidation on KATP channels from different tissues. ROS
lowers the KATP channel activity in cerebral arterioles (Erdos et al., 2004; Ross and Armstead,
2003) and coronary arteries (Miura et al., 2003) but facilitates its opening in cardiac myocytes
(Tokube et al., 1998) and pancreatic β-cells (Krippeit-Drews et al., 1999). Our results suggest
that the differential responses of KATP channels to ROS in these tissues are likely to be due to
different isoforms of KATP channels expressed.
KATP channels consist of Kir6.1-containing channels and Kir6.2-containing channels.
Although the Kir6.2 is the closest family member of Kir6.1, the intrinsic properties of these two
groups of channels are quite different (Hibino et al., 2010). For example, they have different
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biophysical properties and are modulated differently by PKA and PKC (Light et al., 2000; Lin et
al., 2000; Thorneloe et al., 2002); the sensitivities of these channels to ATP and ADP are distinct
(Farzaneh and Tinker, 2008); without ATP, the Kir6.2 channel often opens automatically
whereas the Kir6.1 channel always has low basal activity (Farzaneh and Tinker, 2008; Shi et al.,
2008b; Trapp et al., 1998b). Therefore, the studies of Kir6.2 channel often take the advantage of
its automatic opening whereas the studies of Kir6.1 channel require the KATP channel openers to
activate the channel. In this current study, we found another major difference between these
channels. The Kir6.1/SUR2B channel is inhibited by oxidants and reactive disulfides strongly
whereas Kir6.2/SUR2B channel is barely inhibited by these reagents. These different responses
may attribute to the difference between Kir6.1 and Kir6.2 subunits. However, we cannot rule out
the possibility of the involvement of SUR subunit. The close coupling between Kir6.x and SURx
is well recognized. The SUR is known to interact with the N-terminus but not the C-terminus of
Kir6.x to affect channel gating (Babenko and Bryan, 2002, 2003). Such an interaction may rely
on certain N-terminal residues and produce different conformational supports for distinct Kir6.x
subunits. However, our data do suggest that the cysteine residues in the SUR2B subunit are not
functionally S-glutathionylated, which is supported by our systematic mutagenesis for all the
intracellular cysteine residues in SUR2B subunit (Fig. 6-7).
Previous studies of the oxidant sensitivity of KATP channels were mainly focused on
Kir6.2-containing channels (Yokoshiki et al., 1998). Studies of Kir6.2-containing channels in
native tissues suggest that the application of H2O2 facilitates the opening of these channels,
preferentially through changing the ATP/ADP sensitivity of the Kir6.2-containing channels
(Ichinari et al., 1996; Krippeit-Drews et al., 1999). On the other hand, Kir6.2ΔC26 (truncated
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investigations have shown that Cys42 (the corresponding site of Cys43 in Kir6.1) is the major
site involved in the channel inhibition (Trapp et al., 1998b). Consistently, we have also found
Cys43 in Kir6.1, the counterpart of Cys42 in Kir6.2, to be modulated by exogenous thiol
oxidants. More importantly, this residue in Kir6.1 appears to be a S-glutathionylation site,
although it does not seem to play a leading role compared with Cys176.
Biochemical experiments including western blot and pull-down assay require the use of
Kir6.1 antibodies. Kir6.1 antibodies have been generated from different labs, and are also
commercially available. Interestingly, although specific, antibodies from different sources detect
bands of distinct sizes in different tissue samples. For example, a single band of 35, 44 or 49 kDa
is detected in rat heart tissue from three independent studies (Akao et al., 1997; Morrissey et al.,
2005; Sun et al., 2004), respectively. In rat brain samples, a single band of 51 kDa is detected
(Sun et al., 2004), while another study detects the Kir6.1 band between 37 and 50 kDa in adult
mouse hippocampus (Soundarapandian et al., 2007a). In the present study, we used the Kir6.1
antibodies purchased from Sigma-Aldrich. The size of Kir6.1 reactive-band detected in our study
is close to the band detected from heart tissue by Sun et al (Sun et al., 2004). It is suggested that
the post-translational modification, the natural truncation of Kir6.1 protein during the preparation
and the methods for sample treatments (e.g. lysis reagents, reducing or non-reducing preparation,
etc) may affect the size of Kir6.1 protein from different tissues.
KATP channels have been modeled previously using crystallized bacterial channels as
templates (Antcliff et al., 2005; Bichet et al., 2003; Bryan et al., 2004; Proks and Ashcroft,
2009). In this study the closed state of the Kir6.1 is modeled using the most recently crystallized
eukaryotic Kir2.2 together with bacterial Kir channels as templates. The open state model is
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generated based on the open state KirBac1.1 structural model provided by Dr. Venien-Bryan
(Domene et al., 2005; Kuo et al., 2005). With the information from these structures, a model of
the S-glutathionylation-mediated Kir6.1/SUR2B channel gating is proposed (Fig.6-6I-K). A
conservative residue phenylalanine (Phe146 of KirBac1.1; Phe178 of Kir6.1) located in the
narrowest region of the ion conduction pathway is likely to serve as ―blocking residue/activation
gate‖ that prevents K+ from passing through when the channel is closed (Kuo et al., 2003; Rojas
et al., 2007). When the channel is open, the slide helix moves laterally, exerts strain on the
bottom of the inner helix, resulting in the bending of the inner helix at a weak point, e.g. glycine
residue (Gly175 of Kir6.1). This bending moves the side chain of the blocking residue (Phe178
of Kir6.1) away from the center of the ion-conduction pathway and allows K+ to pass through
(Kuo et al., 2005). In the channel open state, the Cys176 of M2 helix makes a close contact with
the M1 helix. The closest distance between Cys176 and Leu73 in the M1 helix is measured to be
2.8Å. Such a short distance/small space cannot accommodate a GSH moiety (or even a smaller
thiol modulation regent, 2-DTP). Therefore, when the channel is S-glutathionylated, the open
conformation of the channel cannot be achieved.
In the Kir6.2 channel, Cys166 (corresponding to Cys176 in Kir6.1) is suggested to be
involved in the intrinsic channel gating (Trapp et al., 1998a). The channel with the C166S
mutation lost most of its sensitivity to both KATP channel opener and inhibitor with a drastic
augmentation of the channel open probability (Trapp et al., 1998a). However, Cys176 in
Kir6.1/SUR2B channel does not seem to be a general gating site. We have found that
Kir6.1/SUR2B channels with the C176A mutation are still sensitive to both KATP channel opener
and inhibitor, indicating that the general channel gating machinery of Kir6.1/SUR2B channel is
still intact with the Cys176 mutation.
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In contrast to the conserved core domain, the N-terminus of Kir channel shows
considerable variations (Fig. 6-8). The crystal structure of N-terminus of Kir channels cannot be
modeled with a decent resolution. Therefore, we did not attempt to study how the Sglutathionylation of Cys43 affects the protein conformation.
Unlike Cys176 and Cys43, Cys120 does not seem to be involved in S-glutathionylation.
In the Kir2.1 channel, the mutation of Cys122, the counterpart of Cys120 in Kir6.1, results in an
absence of ionic currents even the channels are still expressed (Cho et al., 2000; Leyland et al.,
1999). In our studies, we were able to record the currents from the C120S mutant although the
currents were rather small compared to most of the other mutants. Based on the Kir protein
structure, Cys120 is located on the extracellular interface of the cellular membranes, accessible
to extracellular environments. The accessibility of this residue to extracellular oxidants, as well
as membrane-impermeable PDS but not intracellular GSSG, suggests that Cys120 could be a site
for extracellular redox modulation rather than intracellular S-glutathionylation.
In conclusion, our studies indicate that S-glutathionylation inhibits the Kir6.1/SUR2B
channel by targeting mainly Cys176 in the Kir6.1 subunit. S-glutathionylation at Cys176 is likely
to structurally prevent the pore-forming inner helix from undergoing necessary conformational
change for channel gating, thus retaining the channel in its closed state. The demonstration of the
molecular mechanism underlying S-glutathionylation of the vascular KATP channel with
structural insight into the channel gating should have a profound impact on the understanding of
the post-translational modifications of ion channels.
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Figure 6-1. Redox-mediated vascular KATP channel inhibition. A, whole-cell voltage clamp
was performed on a cell expressing Kir6.1/SUR2B channel. The reversal potential of K+ current
was close to 0 mV by using equilibrate bath and pipette solutions containing 145 mM K+.
Command pulses of − 80 mV were given every 3s. Application of pinacidil (Pin, 10 µM)
markedly augmented the whole-cell currents, which were subsequently inhibited by increased
doses of H2O2 (1 mM and 3 mM). Glibenclamide (Glib, 10 µM), a specific KATP channel
inhibitor, further diminished the channel activity to the basal level. B, in the whole cell
recording, Pin-induced Kir6.2/SUR2B currents responded poorly to high concentrations of H2O2
(3 mM and 10 mM). C, in whole cell configuration, the Pin-activated currents were potently
inhibited by membrane-permeable 2-DTP (50 µM). D, in whole-cell configuration, membraneimpermeable DTNB (50, 200 µM) had modest inhibitory effects on the Kir6.1/SUR2B channel
activity. E, inside-out patch recording was obtained from an HEK cell expressing the
Kir6.1/SUR2B channel with a holding potential of − 60 mV, 2-DTP (3~30 µM) inhibited the
Pin-induced Kir6.1/SUR2B channel progressively. F, increased doses of DTNB inhibited the
Kir6.1/SUR2B channel in a similar manner. G, the effects of H2O2 (3 mM) on the Kir6.1/SUR2B
and Kir6.2/SUR2B channels were compared. H, the dose-effect relationship of extracellular
application of 2-DTP or DTNB on the activity of Kir6.1/SUR2B channel in the whole-cell
configuration was shown. I, the dose-effect relationship of 2-DTP or DTNB application on the
activity of Kir6.1/SUR2B channel in inside-out patch configuration was shown. ***, P<0.001.
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Figure 6-1
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Figure 6-2. The responses of chimerical channels to 2-DTP. A, segments from Kir6.1 were
shown in white and segments from Kir6.2 were shown in black. The effect of 2-DTP (50 µM) on
all the chimerical channels were shown along with the illustrations. Compared with 111, both
211 and 121 showed decreased sensitivities to 2-DTP. Compared with 222, both 122 and 212
had stronger responses to 2-DTP treatments. Statistical analysis revealed that both N-terminus
and core domain were important for channel inhibition by 2-DTP. B-E, representative figures
demonstrated the responses of different constructs to the treatment of 2-DTP.
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Figure 6-2
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Figure 6-3. Identification of the critical sites of cysteine modification. A, schematic
illustration of the approximate locations of the cysteine residues across the hKir6.1 subunit was
shown. B, The effects of 2-DTP (50 µM) on the WT and mutant channels were summarized.
Mutation of Cys43 and Cys176 showed impaired sensitivities to the 2-DTP (50 µM) treatment
using ANOVA analysis. C, Kir6.1-C176A/SUR2B mutant channel was activated by Pin. The
current was resistant to the inhibitory effect of 2-DTP. Glib still inhibited the channel activity. D,
Kir6.1-C43A/SUR2B mutant channel showed impaired responses to 2-DTP-mediated channel
inhibition. E, in another cell expressing Kir6.1-C120S/SUR2B mutant channel, 2-DTP had
substantially inhibitory effect on the channel activity. F, Kir6.1-C120S/SUR2B currents were not
sensitive to DTNB (200 µM), a membrane impermeable 2-PDS (***, P<0.001).
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Figure 6-3
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Figure 6-4. The effect of S-glutathionylation on the WT and mutant channels. A, in Kir6.1C176A/SUR2B mutant channel, 5 mM GSSG only had a slight inhibitory effect on the Pininduced currents in giant inside-out patches. B, Kir6.1-C176A/SUR2B mutant channel was
almost insensitive to the combined treatment of GSH and H2O2, another S-glutathionylation
induction method. C, Kir6.1-C43A/SUR2B mutant channel was inhibited by GSSG (5 mM). D,
Kir6.1-C43A/C176A/SUR2B channel was resistant to the inhibitory effect of GSSG. E,
summary of the effects of GSSG on Cys176, Cys43, Cys120 and Cys43/Cys176 double mutants
in giant inside-out patches was shown. (n=4~6). F, summary of the effects of GSH/ H2O2 on
Kir6.1/SUR2B WT and Kir6.1-C176A/SUR2B mutant channels was shown. *, P<0.05; ***,
P<0.001.
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Figure 6-4
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Figure 6-5. Cys176 impaired the streptavidin pull-down. A, whole cell extracts were obtained
from HEK cells expressing Kir6.1/SUR2B and Kir6.1-C176A/SUR2B channels using RIPA
buffer. The β-actin protein was detected using anti-β-actin antibodies as the loading control
(lower panel). The Kir6.1 proteins and Kir6.1-C176A mutant proteins were detected in the whole
cell extracts using anti-Kir6.1 antibodies. With the loading of the same amount of protein
extracts, the anti-Kir6.1 antibodies detected bands of Kir6.1/SUR2B WT channel and Kir6.1C176A/SUR2B mutant channel in a similar density (middle panel). Same amount of protein
extracts (100 µg) from HEK293 cells expressing WT or mutant channels were subjected to the
pull-down assay by same amount of streptavidin-beads (1 mg). Western blot using antibodies
aganst Kir6.1 protein showed that the density of the Kir6.1-C176A-reactive band was much
weaker compared with that of Kir6.1 WT channel (upper panel). B, The band densities of Kir6.1C176A mutant channel after pull down was normalized to that of Kir6.1 WT channel with the
adjustment of inputs. Data was averaged from five individual repeats. ***, P<0.001.
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Figure 6-5
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Figure 6-6. Structural modeling of Kir6.1 S-glutathionylation at Cys176. A, structural
modeling of the two opposing monomers of Kir6.1 pore-forming domain in the closed state was
shown. B, structural model of the Kir6.1 pore-forming domain in its open state was shown. C-E,
close-up views of the GSH incorporated into Cys176 of M2 inner helix were shown. D and E
were 90 degree turns of the view from C. F-G, intracellular view of the pore-lining helices of
Kir6.1 (perpendicular to the axis of M1 outer helix, blue) in the closed state model. (G, with a
GSH moiety; F, without a GSH moiety). H, the same intracellular view of Kir6.1 in the open
state model was shown. Compared with F, the M2 inner helix (red) was bent leftward and
twisted slightly, making Cys176 facing directly to the M1 outer helix (blue) where there was the
residue Leu73. The distance between the sulfur atom of Cys176 and the closest carbon atom of
Leu73 was 2.8Å in the open state compared with 9.2Å in the closed state. Structural elements are
colored: blue, M1 outer helix; red, M2 inner helix; purple, M0 slide helix; black, selectivity
filter; GSH, in standard amino acid colors. I-K, proposed models for S-glutathionylation
mediated channel gating. I, schematic view of KATP channel in its closed state. The ―activation
gate‖ Phe178 blocks the pore and prevents the ion from passing through. J, the administration of
KATP channel opener causes a conformational change of KATP channel: Inner helix bends at
Gly175 and moves the gate (Phe178) away from the ion-conduction pathway to facilitate
potassium ions to pass through. K, S-glutathionylation at Cys176 residue results in the
incorporation of GSH that occupies the space between inner and outer helices. The addition of
GSH prevents the channel from entering its open state.
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Figure 6-6
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Figure 6-7 Systematic mutagenesis of cysteine residue in SUR2B subunit of Kir6.1/SUR2B
channel. The mutation of all intracellular cysteine residues of SUR2B was created and expressed
with wild-type Kir6.1. The mutants were tested with 2-DTP (50 µM). None of these mutants
acted differently from the wild-type Kir6.1/SUR2B channels.
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Figure 6-7
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Figure 6-8 Sequence alignments of hKir6.1 with KirBac1.1, KirBac3.1 and cKir2.2. M0
slide helix was colored gray, M1 outer helix was colored pink; selectivity filter was colored dark
yellow; M2 inner helix was colored red. Important residues of Kir6.1 described in this study
were also highlighted: Gly175, green; All cysteine residues, yellow; Phe178, teal.
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7. RESULT 3: PKA-DEPENDENT ACTIVATION OF THE VASCULAR SMOOTH
MUSCLE ISOFORM OF KATP CHANNELS BY VASOACTIVE INTESTINAL
POLYPEPTIDE AND ITS EFFECT ON RELAXATION OF THE MESENTERIC
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7.1 Abstract
Vasoactive intestinal polypeptide (VIP) is a potent vasodilator, and has been successfully
used to alleviate hypertension. Consistently, disruption of VIP gene in mice leads to
hypertension. However, its downstream targets in the vascular regulation are still not well
demonstrated. To test the hypothesis that the vascular smooth muscle isoform of KATP channels
is a downstream target of the VIP signaling, we performed the studies on the Kir6.1/SUR2B
channel expressed in HEK293 cells. We found that the channel was strongly activated by VIP.
Through endogenous VIP receptors, the channel activation was reversible and dependent on VIP
concentrations with the midpoint-activation concentration ~10 nM. The channel activation was
voltage-independent and could be blocked by KATP channel blocker glibenclamide. In cellattached patches, VIP augmented the channel open-state probability with modest suppression of
the single channel conductance. The VIP-induced Kir6.1/SUR2B channel activation was blocked
by PKA inhibitor RP-cAMP. Forskolin, an adenylyl cyclase activator, activated the channel
similarly as VIP. The effect of VIP was further evident in the native tissues. In acutely
dissociated mesenteric vascular smooth myocytes, VIP activated the KATP currents in a similar
manner as in HEK293 cells. In endothelium-free mesenteric artery rings, VIP produced
concentration-dependent vasorelaxation that was attenuated by glibenclamide. These results
therefore indicate that the vascular isoform (Kir6.1/SUR2B) of KATP channels is a target of VIP.
The channel activation relies on the PKA pathway and produces mesenteric arterial relaxation.
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7.2 Introduction
VIP is a 28-amnio-acid peptide hormone and neurotransmitter present in multiple organs
and systems. VIP has broad effects on cellular functions including vasodilation, water
reabsorption, neurotransmission, insulin secretion and immunomodulation (Delgado et al., 2001;
Straub and Sharp, 1996; Tsutsumi et al., 2002). These biological effects are mediated by specific
VIP receptors (VPAC1 and VPAC2), both of which are coupled to G-proteins, primarily the GS
proteins (Laburthe and Couvineau, 2002).
As a potent vasodilator, VIP containing nerve terminals innervate a variety of blood
vessels in systemic and pulmonary circulations (Henning and Sawmiller, 2001). VIP released
from the nerve terminals produces vascular smooth muscle relaxation. Such a vasodilation effect
is 50-100 times more potent than acetylcholine(Henning and Sawmiller, 2001). Administration
of VIP to patients with severe cardiovascular diseases such as primary pulmonary hypertension
results in substantial improvement in their conditions without adverse side-effects (Petkov et al.,
2003). Moderate pulmonary arterial hypertension has been observed in mice lacking the VIP
gene (Hamidi et al., 2006; Said et al., 2007). By taking the advantage of the vasodilation effects,
several species of animals have developed VIP-like peptides that are lethal vasodilatory toxins
serving for defense and predatory purposes(Blank et al., 1986; Hoshino et al., 1984) (Pohl and
Wank, 1998).
The downstream molecules of VIP in the vasodilation effect are still not fully understood
(Henning and Sawmiller, 2001). In the vascular smooth muscle cells, the influx of Ca++ through
voltage-dependent Ca++ channels contributes to vessel constriction, while the preclusion of this
event leads to the vasodilation (Hill et al., 2001; Nilsson, 1998). The opening and closure of
these Ca++ channels is largely controlled by membrane potentials. Activation of the vascular
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KATP channels hyperpolarizes the vascular smooth muscle cells, prevents the Ca++ influx, and
relaxes blood vessels. Therefore, the vascular KATP channels play an important role in vascular
tone regulation (Brayden, 2002).
Functional KATP channels are made of four pore-forming subunits Kir6.x (Kir6.1 or
Kir6.2) and four regulatory subunits sulfonylurea receptor SURx (SUR1, SUR2A or SUR2B)
(Quayle et al., 1997). The former belongs to the inwardly rectifying K+ channels, and the latter is
a member of the ATP-binding cassette (ABC) protein family (Babenko et al., 1998; Deeley et al.,
2006; Seino, 1999). A combination of deferent Kir6.x and SURx results in distinct KATP
channels, such as the Kir6.2/SUR1 channel in pancreatic β-cells and the Kir6.2/SUR2A channel
in cardiac muscles (Yokoshiki et al., 1998). The Kir6.1/SUR2B channel is the major isoform of
KATP channels in vascular smooth muscles, although there is evidence that the Kir6.2 also forms
functional channels with SUR2B in blood vessels (Cao et al., 2002; Jansen-Olesen et al., 2005;
Tricarico et al., 2006). The biophysical and pharmacological properties of the Kir6.1/SUR2B
channel are comparable to those of KNDP channels found in native coronary and mesenteric
arteries (Zhang and Bolton, 1995; Zhang and Bolton, 1996). Consistently, disruptions of the
Kcnj8 (Kir6.1) or ABCC9 (SUR2) genes in mice cause abnormalities in coronary circulation,
sudden cardiac death and fatal susceptibility to endotoxemia (Chutkow et al., 2002; Kane et al.,
2006; Miki et al., 2002).
Previous studies have suggested that the vascular KATP channels are subjected to
phosphorylation regulation by protein kinases A, C and G (PKA, PKC, PKG), allowing them to
respond to several vasoactive hormones and neurotransmitters (Quinn et al., 2004; Shi et al.,
2007a; Shi et al., 2007b; Thorneloe et al., 2002). Since the PKA signaling cascade can be
activated by VIP, it is possible that the vascular smooth muscle KATP channels play a role in
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vasodilation effect of VIP. To test the hypothesis, we performed these studies on the
Kir6.1/SUR2B channel expressed in HEK293 cells, cell-endogenous KATP channels from
dissociated smooth myocytes and isolated mesenteric arterial rings.
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7.3 Result
7.3.1. Activation of the Kir6.1/SUR2B channel by VIP in HEK293 cells
The Kir6.1/SUR2B channel was transiently expressed in the HEK293 cells, and whole
cell voltage-clamp was performed on the GFP-positive cells. The cell was exposed to an
extracellular perfusion solution after whole-cell configuration formation. Most cells showed
small stable baseline currents, and the currents in some cells increased slightly reaching a steady
state within a few minutes (Fig.7-1A). When VIP (30 nM) was applied to the cell in the
perfusion solution, the whole-cell currents increased rapidly and reached a plateau in about 2-3
min. KATP channel opener pinacidil (Pin, 10 µM) strongly augmented the currents that was
subsequently inhibited by glibenclamide (Glib, 10 µM) (Fig. 7-1A). Thus we used 10 µM Pin
and 10 µM Glib throughout the study unless otherwise stated. Another KATP channel opener,
diazoxide (100 µM), opened the channel to the similar degree as Pin, and its effect was also
totally blocked by Glib (Fig.7-8). The effect of VIP was completely blocked in the presence of
10 µM Glib suggesting that Kir6.1/SUR2B channel is targeted by VIP (Fig. 7-1B). For
quantitative analysis, the effect of VIP was normalized between the baseline current and the
current activated by 10 µM Pin. Under such a condition, the currents activated by 30 nM VIP
averaged 58.0±3.4% (n=5).
Several control experiments were done. The outward currents studied together with the
inward currents using depolarizing (− 80 mV) and hyperpolarizing (80 mV) command pulses
were affected by VIP and other K+ channel blockers in a similar proportion as the inward
currents (Fig. 7-8; Fig. 7-9). Both the Pin-activated inward and outward currents were insensitive
to 30 µM 4-aminopyridine (4-AP) and 100 nM charybdotoxin (ChTX), specific blockers of KV
and BK channels, respectively, but inhibited by 1 mM tetrabutylammonium (TBA) (Fig. 7-9).
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Finally, the Pin- and Glib-sensitive currents were not observed in cells transfected with the
expression vector alone (Fig.7-3B), indicating that the VIP-elicited current is conducted through
KATP channels.
The activation of the Kir6.1/SUR2B channel by VIP showed clear concentrationdependence. Evident increase in the current amplitude was observed with the VIP concentration
as low as 1 nM, and stronger activation occurred with higher concentrations (Fig. 7-2A). The
maximum effect (58.0±3.4%) was reached with 30 nM VIP (Fig. 7-2B).
Previous studies have shown that the VIP receptor VPAC1 is constitutively expressed in
HEK293 cells (Reubi, 2000; Simmons, 1990). We found that the Kir6.1/SUR2B channel was
activated by VIP when expressed in HEK293 cells without exogenous VIP receptors. Such a
channel activation was significantly diminished by the VIP receptor antagonist VIP6-28
(16.1±3.9% 10 nM VIP with the presence of VIP 6-28 vs 35.0±7.9% 10 nM VIP without VIP 628; P<0.05, n=15) (Fig. 7-2C). When the HEK293 cells were transfected with the VPAC2
receptor (the VPAC1 receptor cDNA is not commercially available), VIP (100 nM) did not show
any significant additional effect on the Kir6.1/SUR2B channel (49.2±4.5% with the VPAC2
receptor vs. 52.8±3.4% without; P>0.05, n=7). These results suggest that the endogenous VIP
receptors in the HEK293 cells mediate the VIP effect, consistent with previous observations on
the presence of endogenous VIP receptors in HEK293 cells (Simmons, 1990).
7.3.2. Biophysical basis for the Kir6.1/SUR2B channel activation
When step voltage protocols were applied, the current activation by VIP was observed
across the whole voltage range from -120 mV to 120 mV (Fig.7-3A). The I-V relationship of the
VIP-activated and Pin-activated currents was normalized to the current amplitude at − 120 mV
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and plotted in the same X-Y axis system. Under the condition, the two I-V plots superimposed
with each other nicely, indicating that the current activation by VIP is voltage-independent (Fig.
7-3B, C). Such currents were not seen in cells transfected with the expression vector alone (Fig.
7-3D).
To understand the biophysical basis for the Kir6.1/SUR2B channel activation, singlechannel recordings were performed in cell-attached patches. Exposure to VIP (100 nM)
augmented the channel open-state probability (NPO 0.005±0.002 at baseline, 0.048±0.006 with
VIP, and 0.116±0.017 with Pin, n=5) (Fig. 7-4A). The single-channel conductance was slightly
inhibited by VIP (34.9±0.9 pS before vs. 31.7±1.7 pS after VIP treatment, P<0.05, n=10; Fig. 74B,C). At baseline, the closed time was 164.7±74.1 ms (n=6), the level-1 open time was
1.77±0.53 ms (n=6), and the level 2 open time was 0.73±0.19 ms (n=6). During the VIP
exposure, the closed time was reduced to 59.1±7.6 ms (n=7, P<0.05), while the level 1 open time
(2.28±0.45 ms, n=7) and level 2 open time (1.06±0.15 ms, n=7) did not change significantly,
indicating that VIP increases the NPo via suppression of the closed time.
7.3.3. PKA dependence
Previous studies have shown that KATP channels are regulated by both PKA and PKC
(Beguin et al., 1999; Lin et al., 2000; Quinn et al., 2004). VIP receptors (VPAC1 and VPAC2)
are primarily coupled to GS, stimulation of which can lead to activation of PKA pathway
(Laburthe and Couvineau, 2002; Martin Shreeve, 2002). To elucidate whether the activation of
the Kir6.1/SUR2B channel by VIP depends on the PKA pathway, 8-(4-chlorophenylthio)
adenosine-3′,5′-cyclic monophosphorothioate Rp-isomer (RP-cAMP), a PKA inhibitor, was
applied in both the pipette solution (200μM) and in perfusion solution (100μM). In the presence
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of RP-cAMP, the current activation by 100 nM VIP was significantly reduced to 11.9±6.9%
(P<0.01, n=10 in comparison to control) (Fig. 7-5A, E).
As the adenylyl cyclase is activated by GS, we studied the Kir6.1/SUR2B currents with
forskolin, a potent adenylyl cyclase activator. Exposure of the cell to 10 μM forskolin strongly
activated the Kir6.1/SUR2B channel. Such an effect was not significantly different from the
channel activation by 100 nM VIP (P>0.05, Fig. 7-5B, E). The forskolin-activated currents also
showed identical characteristics to the current activated by VIP in their I-V relationship (Fig. 75D in comparison with Fig. 7-3A). After the currents were activated by VIP, forskolin had no
additional effect (Fig. 7-5C, E), further suggesting that the VIP and forskolin share the same
intracellular signaling pathway in regulating the channel activity.
7.3.4. Effects of VIP on KATP channels in vascular smooth myocytes
The effect of VIP on cell-endogenous KATP channels of the vascular smooth myocytes
(VSM) dissociated acutely from mesenteric arterials. Under the same recording condition as for
the HEK293 cells, the inward K+ currents were recorded from the VSMs. The VSM-endogenous
current had single-channel conductance 34.8±1.1 (n=4) similar to the Kir6.1/SUR2B current
expressed in HEK cells (34.9±0.9, n=11). The currents were activated with the treatment of 100
nM VIP, further augmented by Pin (10 µM), and subsequently inhibited by Glib (10 µM) (Fig. 76), consistent with the Kir6.1/SUR2B channel activation observed in HEK293 cells.
To further understand whether the regulation of KATP channel by VIP affects vascular
tone, we studied isometric contractions of endothelium-free mesenteric artery rings.
Administration of phenylephrine (PE) led to a rapid contraction of the arterial rings which lasted
over 30 min without clear desensitization. The failure of 1 µM carbamylcholine to dilate the ring
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after contraction with PE was the evidence of functional endothelial ablation (Fig. 7-7A). When
VIP was applied, the rings relaxed in a concentration-dependent manner (Fig. 7-7B, D). Such a
VIP-induced vasorelaxation was markedly attenuated by a pretreatment with 1 µM Glib (Fig. 77C, D), indicating that the KATP channels activation play an important role in the VIP-induced
relaxation.

135

7.4 Discussion
Our studies have shown that the Kir6.1/SUR2B channel is a downstream target of VIP.
The channel is strongly activated by VIP with the midpoint concentration for the channel
activation ~10 nM. The channel activation is likely mediated through the VIP receptor, adenylyl
cylcase and PKA signaling system. Such KATP channel activation tends to hyperpolarize the cell
and relaxes the vascular smooth muscle, which is consistent with our data showing that VIP
produces KATP channel-dependent relaxation of the mesenteric arteries.
Several potential downstream effector molecules have been suggested for the
vasodilation effect of VIP. In the isolated perfused rat heart, selective activation of VIP receptors
produces vasodilation of the coronary circulation. Such a vasodilation effect can be blocked by
glibenclamide but not 4-aminopyridine, suggesting that KATP channels are involved (Sawmiller
et al., 2006; Tanaka et al., 1997). Another study suggests that the vasodilation effect of VIP is
mediated through glibenclamide-insensitive channels (Hattori et al., 1992; Kawasaki et al.,
1997). Clearly, VIP may affect vascular tones via multiple mechanisms that remain to be
demonstrated, as these previous studies relied on sulfonylureas that are known to affect other ion
channels as well (Ishida-Takahashi et al., 1998; Konstas et al., 2002). Using the cloned channel
in the HEK expression system, we have revealed that Kir6.1/SUR2B channel is one of the
downstream molecules. In the mesenteric VSMs, activation of Maxi-K channels also contributes
to the vasorelaxation response to VIP, in which the cAMP-dependent signaling pathways seem to
be involved (Liu et al., 1999). In the gastrointestinal system, VIP can produce relaxation of the
sphincter of Oddi which can be attenuated by glibenclamide (Sari et al., 2004). Consistent with
these previous studies, our results show that VIP relaxes isolated mesenteric rings, an effect that
can be blocked by glibenclamide. Our studies in a heterologous expression system have indicated
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that the cloned Kir6.1/SUR2B channel indeed is activated by VIP. As the Kir6.1/SUR2B channel
is expressed in vascular smooth muscles (Li et al., 2003; Morrissey et al., 2005), and as the
channel protein may be phosphorylated by PKA (Quinn et al., 2004), it is likely that that the
activation of the Kir6.1/SUR2B channel contributes to the vasodilation effect of VIP.
The KATP channels play an important role in membrane potentials and cell activity
(Quayle et al., 1997; Seino, 1999). These K+ channels are inhibited by physiological
concentrations of ATP, and are open when ATP level drops during metabolic stress. Such a
property allows them to regulate several cellular functions during metabolic stress, including
vascular tone regulation, myocardium excitability control, neuronal responses to hypoxic
ischemia, insulin-secretion in pancreatic β-cells, and glucose uptake in striated muscles (Quayle
et al., 1997; Seino, 1999; Yokoshiki et al., 1998). The Kir6.1/SUR2B channel is likely to be the
major isoform of KATP channels in vascular smooth muscles, whose pharmacological properties
resemble those of the native KNDP channels in vascular smooth myocytes(Teramoto, 2006;
Yamada et al., 1997; Yamada and Kurachi, 2004). The involvement of Kir6.1/SUR2B in
vascular tone regulation has been demonstrated in both physiological and pathological
conditions. Activation of these KATP channels in response to local regulators hyperpolarizes
vascular smooth muscles and dilates resistance arteries leading to redistribution of the blood
flow(Quayle et al., 1997), while the disruption of the Kcnj8 (Kir6.1) or ABCC9 (SUR2) genes in
mice causes abnormalities in coronary circulation, sudden cardiac death and fatal susceptibility
to endotoxemia (Chutkow et al., 2002; Kane et al., 2006; Miki et al., 2002). The vascular KATP
channel is regulated by a variety of vasoactive substances especially circulating hormones and
neurotransmitters. Several studies have suggested that the regulation of the vascular K ATP
channel is achieved via phosphorylation of the channel proteins by protein kinases that are
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activated through specific intracellular singling pathways downstream to the VIP receptors
(Quayle et al., 1994; Wellman et al., 1998). Therefore, the understanding of the KATP channel
function in vascular tone control depends on the demonstration of the precise signal pathway
underlying the channel modulation.
Several other intracellular signaling pathways may be involved in the vasodilation effect
of VIP. The VIP effect has been shown to rely on the VPAC2 receptor in the coronary
circulation (Sawmiller et al., 2006). Because of the lack of specific receptor blockers, we could
not differentiate VPAC1 from VPAC2 in our studies. According to previous studies, the VPAC1
is expressed in the HEK293 cells (Reubi, 2000; Simmons, 1990), suggesting that the
Kir6.1/SUR2B channel activation may be produced by VPAC1. However, we cannot rule out the
involvement of VPAC2 as both VPAC1 and VPAC2 receptors are coupled to GS leading to
activation of adenylyl cyclase and PKA.
Although the VIP receptor - adenylyl cylcase - PKA system seems critical, VIP also can
activate PKG pathway (Kim et al., 2006; Kurjak et al., 2001). In addition, the VIP-induced
relaxation of aorta and uterine arteries has been shown to be produced by nitric oxide (NO)
released from the endothelial cells (Pesic et al., 2004; Pomerleau et al., 1997). Another study
however suggests that NO synthesis is not affected by VIP, while stimulation of endogenous NO
production provokes VIP release from nerve terminals (Wellman et al., 1998). Since
endothelium-free arterial rings were used, our results from the present study suggest that the
effect of VIP on vasorelaxation is NO - independent. Because of the presence of these diverse
signaling molecules, distinct intracellular signaling pathways appear to play a role in the VIP
signaling targeting at perhaps different effector molecules. Thus, the demonstration of the
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adenylyl cyclase - PKA - Kir6.1/SUR2B pathway in the present study is of significance in the
understanding the vascular effect of VIP.
In conclusion, our results indicate that the Kir6.1/SUR2B channel is a downstream target
of VIP signaling. The activation of the major vascular isoform of KATP channels can produce
hyperpolarization and relaxation of vascular smooth muscles, which is consistent with the effect
of VIP on mesenteric arteries. The information that we have found for the VIP signaling pathway
may be useful for the manipulation of specific membrane and intracellular signal molecules in
the control of vascular tones.
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Figure 7-1. Activation of the Kir6.1/SUR2B channel by VIP in HEK293 cells. A, whole-cell
currents were recorded from a cell transfected with Kir6.1/SUR2B. The bath solutions contained
145 mM K+ so that the reversal potential of K+ currents is close to 0 mV. The recording pipette
was filled with the same solution with the addition of 1 mM ATP, 0.5 mM ADP, and 1 mM free
Mg++. Application of VIP (30 nM) increased the whole-cell currents rapidly and reached a
plateau in about 3 min. KATP channel opener pinacidil (Pin, 10 µM) strongly augmented the
currents that was potently inhibited by glibenclamide subsequently (Glib, 10 µM). Note that
arrows point to where each bottom trace was taken from. B, the effect of VIP was totally blocked
in the presence of 10 µM Glib.
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Figure 7-2. Concentration dependent channel activation by VIP. A-B, the activation of the
Kir6.1/SUR2B channel by VIP was concentration-dependent with VIP concentration for a half
current activation ~10nM. C, the effect of VIP (10 nM) was significantly diminished in the
presence of VIP receptor blocker VIP6-28 (100 nM).
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A
VIP 1

3

10

30

100 nM
31 42

31 42

13 42

0.00200
0.00593
0.00200minmin
-0.0934
-0.0000
-0.0851
0.0949nAnA

C

30
20
10
3

10

30

100

30

*

20
10
0
VI

1

40

VIP (nM)

P6
-2
8

40

VI

50

0

50

% Channel activation

% Channel activation

60

P

B

143

Figure 7-3. Voltage independence. A, voltage dependence was studied with step command
pulses from – 120 mV to 120 mV from a holding potential of 0 mV. The current activation by
VIP was observed across the whole voltage range in the HEK cell. B, similar current activation
was not seen in another cell transfected with the vector alone. C, the I-V relationship of VIP and
Pin was plotted by normalized to the current at – 120 mV. The I-V plots superimposed with each
other almost completely indicating the effect of VIP is not voltage-dependent.
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Figure 7-3
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Figure 7-4. Effect of VIP on single-channel properties. A, single-channel currents were
recorded in a cell-attached patch. The lower trace in each panel is an expansion from the record
of upper trace between arrows. Two active channels were seen at baseline with rather low
channel activity (NPo 0.001). When the cell was exposed to 100 nM VIP, the single-channel
activity was augmented (NPo 0.028). The channel activity was further stimulated with 10 M
(NPo 0.152). B, single channel conductance was measured in a cell-attached patch from another
cell with a ramp voltage from – 100 to 100 mV. An active channel was observed with 100 nM
VIP. The straight line represents a slope conductance of 36 pS. C, the slope conductance
increased modestly, and an additional active channel was recruited in the presence of pinacidil.
The slope conductance is 40 pS for both.
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Figure 7-5. PKA dependence of the Kir6.1/SUR2B channel activation by VIP. A, RP-cAMP, a

potent PKA inhibitor, was applied in both the pipette solution (200 µM) and the perfusion
solution (100 µM). The VIP-activated Kir6.1/SUR2B currents were greatly attenuated in the
presence of RP-cAMP. B, the Kir6.1/SUR2B channel was activated by 10 µM forskolin, an
adenylyl cyclase activator. C, the forskolin-activated current had similar characteristics as the
VIP-activated current showing no evident voltage-dependence. D, after the currents were
activated by VIP, forskolin had no additional effect. E, summary of VIP effects in the presence
or absence of RP-cAMP and forskolin. The VIP-induced channel activation was significantly
reduced in the presence of RP-cAMP (**, P<0.01, n=10). Forskolin and VIP did not produce any
significant additional activation in comparison to the effect of VIP alone.
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Figure 7-5
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Figure 7-6. Activation of endogenous KATP channels in vascular smooth myocytes. A, K+ currents

were recorded in the same condition as in Fig. 1. The currents were augmented with an exposure
to 100 nM VIP. The currents were further activated by Pin and inhibited by Glib. B, an acutely
dissociated vascular smooth myocyte with the recording pipette on the right side. C, the current
amplitude increased significantly with VIP exposure. **, P=0.01.
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Figure 7-7. Involvement of KATP channel in the VIP-induced vasorelaxation. A, the effect of
VIP was studied in an endothelium-free mesenteric arterial ring in-vitro. Administration of 1 µM
phenylephrine (PE) led to a strong and persistent contraction of the arterial ring. A subsequent
exposure to 1 µM carbamylcholine relaxed the ring only slightly. B, the application of VIP in the
presence of PE dilated the artery rings in a concentration-dependent manner. C, such
vasorelaxation effect was markedly attenuated by a 30min pretreatment with 1 µM
glibenclamide (Glib). D, summary of the vasodilation effect of VIP on PE-induced
vasoconstriction in the presence or the absence of Glib. *, P<0.05; ***, P<0.001.
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Figure 7-8. Activation of the Kir6.1/SUR2B channel by diazoxide (DZX) and pinacidil. A,
DZX (100 µM) activated the Kir6.1/SUR2B channel similarly as 10 µM Pin, which was also
inhibited by 10 µM Glib. B, summary of the currents activated by DZX and Pin (n=3).
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Figure 7-9. The effect of different K+ channel blockers on K+ currents. A, the pretreatment of
4-aminopyridine did not block the effect of VIP- and diazoxide (DZX)-induced currents. B, pininduced K+ currents were insensitive to charybdotoxin. C, TBA (non-selective K+ channel
blocker) partially blocked the Pin-induced K+ currents. D, summary of effects of the K+ channel
blockers. E, the VIP-induced channel activation was not blocked by 4-AP treatment (n=3~5).

156

Figure 7-9

Baseline

2 nA

B

Baseline

Pin

2 nA

Glib

100 nM ChTX / Pin

Pin

Glib

1 mM TBA / Pin

Glib

1 min

E

80

% Inhibition

100 µM DZX

1 min

Baseline

D

100 nM VIP / 30 µM 4-AP

1 min

3 nA

C

30 µM 4-AP

% Activation

A

60
40
20
0

4-AP

ChTX

TBA

0.7
70
0.6
60
0.5
50
0.4
40
0.3
30
0.2
20
0.1
10
0.0
0

1

VIP

2

VIP/4-AP

157

8 GENERAL DISCUSSIONS
8.1 KATP channel modulation by PTMs
8.1.1 KATP channel modulation by PKA and PKC
Based on the distinct pore-forming subunits, KATP channel can be separated into Kir6.1containing channels and Kir6.2-containing channels. Both groups have been shown to be
modulated by PKA and PKC signaling pathways. In general, PKA activation augments both
Kir6.1 and Kir6.2-containing channels (Shi et al., 2007b; Yang et al., 2008) but the
phosphorylation sites were debatable (Beguin et al., 1999; Lin et al., 2000). For example, it was
reported that PKA activated the Kir6.2-containing channel (Kir6.2/SUR1) by phosphorylation of
Ser372 of the Kir6.2 subunit in one report (Beguin et al., 1999). Another report supports the
notion that PKA activated a variety of Kir6.2-containing channel (Kir6.2/SUR1, Kir6.2/SUR2B
and Kir6.2ΔC36) but argues that Thr224, rather than the Ser372, is the phosphorylation site (Lin
et al., 2000). A third report suggests that ADP plays an important role in PKA mediated channel
modulations and identified Ser1448 as the phosphorylation site (Light et al., 2002). Although
reports are consistent regarding the activation effect of PKA on the Kir6.1-containing channel,
the site identified in our lab (Ser-1387) (Shi et al., 2007b) is different from the sites reported
previously (Ser385 of Kir6.1, Thr633 and Ser1465 of SUR2B) (Quinn et al., 2004). We suggest
that different NDPs used in the experimental conditions, different basal activation level and
different experimental approaches, may be responsible for this discrepancy.
The effect of PKC on Kir6.1-containing channels is distinct from the Kir6.2-containing
channels (Quinn et al., 2003; Thorneloe et al., 2002). PKC inhibits the activity of Kir6.1containing channel (Kir6.1/SUR2B) (Shi et al., 2007a; Shi et al., 2008b) while it activates the
Kir6.2-containing channels (Kir6.2/SUR1, Kir6.2/USR2A, Kir6.2/SUR2B and Kir6.2ΔC26).
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The phosphorylation sites of Kir6.1 have been found to consist of at least 4 serine residues
located at the distal C-terminus of the Kir6.1 subunit (Shi et al., 2008b), while the
phosphorylation site of Kir6.2 has been found to be at the Thr180 of Kir6.2 protein (Light et al.,
2000).
Kir6.1/SUR2B channel are important vascular tone regulators. The opening of the
Kir6.1/SUR2B channel contributes to vasodilation while the closure of the channel facilitates the
vasoconstriction. Because many vasodilators are coupled to the PKA pathway (Yang et al., 2008)
and vasoconstrictors act mostly frequently on the PKC pathway (Shi et al., 2007a), the activation
of Kir6.1/SUR2B channel by PKA and the closure of Kir6.1/SUR2B channel by PKC fit very
well with the actions of vasodilators and vasoconstrictors.
8.1.2 KATP channel modulation by oxidants and thiol modulating reagents
It is known that KATP channels are modulated by thiol-modifying reagents. The KATP
channels expressed in ventricular myocytes (supposedly Kir6.2/SUR2A isoform) are inhibited by
thiol modifying agents like p-chloromercuri-phenylsulfonic acid (pCMPS), 5-5'-dithio-bis(2nitrobenzoic acid) [DTNB], and thimerosal (Coetzee et al., 1995). Interestingly, GSSG (3 mM) is
unable to block the KATP channel activity in ventricular myocytes (mainly contain Kir6.2containing channels) (Coetzee et al., 1995), which is consistent with our studies that Sglutathionylation does not have functional modification effect on Kir6.2-containing channels.
Moreover, a study of cloned KATP channel (Kir6.2/SUR2B) shows that pCMPS inhibits the
channel activity by targeting the Cys42 located in the N terminus of the Kir6.2 subunit (Trapp et
al., 1998b).
Other studies using different thiol-modifying reagents like N-ethylmaleimide (NEM, 1
mM), DNTB (1 mM) have shown that these agents can also inhibit the KATP channels in insulin159

secreting cells (Lee et al., 1994; Matsuo et al., 1999) and muscle fibers (Weik and Neumcke,
1989). Interestingly, these inhibitory effects of thiol-modifying regents also rely on the
concentration of ATP (Lee et al., 1994; Weik and Neumcke, 1989), indicating that these cysteine
modifications may have a cross-talk with the ATP/ADP sensing domains of the KATP channels.
In contrast to the thiol-modifying agents, the effect of ROS on the KATP channel activity
is not consistent among different isoforms of KATP channels. ROS lower the KATP channel
activity in cerebral arterioles (Erdos et al., 2004) and coronary arteries (Miura et al., 2003), but
facilitates its opening in cardiac myocytes (Tokube et al., 1998) and pancreatic β-cells (KrippeitDrews et al., 1999). The differential responses of KATP channels in these tissues are likely to be a
result of different isoforms of KATP channels expressed in these tissues.
Although ROS mainly modify the cysteine residues in a similar way like thiol-modifying
agent, studies on Kir6.2-containing channels suggest that the opening of these channels in native
tissues by the application of H2O2 is preferentially through changing the ATP/ADP sensitivity of
these channels (Ichinari et al., 1996; Krippeit-Drews et al., 1999). Depending on the local
environment of the target cysteine, H2O2 may mediate different redox reactions causing the
formation of either disulfide bond, S-nitrosylaiton, S-glutathionylation, or other intermediates.
These different moieties added through these modifications may be responsible for the different
effects of H2O2 on distinct channels.
8.1.3 KATP channel modulation by NO
Nitric Oxide (NO) is the first identified as gaseous signaling molecule that plays a critical
role in the vasodilaton. It has been found that NO activates the Kir6.2/SUR2B isoform of KATP
channel indirectly via the Ras/MAPK (mitogen-activated protein kinase) signaling pathway (Lin
et al., 2004). Later studies show that NO activates Kir6.2/SUR1 channel via the cGMP/PKG
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pathway (Chai and Lin, 2008). This regulation relies on the ROS/calmodulin signaling cascade
and activates the KATP channel in a SUR1 subunit dependent manner (Chai and Lin, 2010). For
KATP channel of β–cells, studies show that NO has a dual effect on the channel activity: at low
levels NO inhibits the Kir6.2/SUR1 channel via a cGMP dependent pathway, while higher levels
of NO activate the channel in a cGMP-independent manner (Sunouchi et al., 2008). NO activates
KATP channels of DRG neurons in the absence of cGMP/PKG signaling compounds in excised
patch condition (Kawano et al., 2009). This modulation can be reversed by DTT and blocked by
thiol-alkylating agent NEM, suggesting direct S-nitrosylation (Kawano et al., 2009). Further
mutagenesis studies of Kir6.2/SUR1 channel demonstrate that the NBD1 of the SUR1 subunit is
the target of S-nitrosylation by NO (Kawano et al., 2009). Besides these plasma membrane KATP
channels, mitochondrial KATP channels have also been studied with NO, which are directly
activated (Ljubkovic et al., 2007). In our studies, we did not observe a clear effect of NO on the
activity of Kir6.1/SUR2B channel. We believe that the inconsistent results might be due to the
redox state of the micro-environment of the channels we studied. It would be interesting to test if
ONOO─, the molecule formed by ROS and NO, may have a modulatory effect on the
Kir6.1/SUR2B channel.
8.1.4 KATP channel modulation by H2S
Hydrogen sulfide (H2S) is a gaseous messenger molecule that is generated in vivo from
L-cysteine through the enzyme β–synthase (CBS) and cystathionine γ–lyase (CSE) (Wang,
2002). It causes vasodilation, inhibits insulin secretion, and regulates inflammation (Pearson et
al., 2006). Endogenous H2S could modulate proteins through S-sulfhydration, which converts the
–SH group of cysteine to –SSH group (Mustafa et al., 2009). Many proteins are found to be
regulated by H2S (Mustafa et al., 2009) and KATP channel is among the first few being identified
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(Tang et al., 2005). One study shows that H2S serves as a gasotransmitter, relaxing the
mesenteric artery through the opening of vascular KATP channels. The effect of H2S is
independent the cGMP pathway mediated by NO (Tang et al., 2005). Further studies found that
cloned Kir6.1/SUR1 channel can also be activated by H2S through the modulation of Cys6 and
Cys26 located on the extracellular N terminal of SUR1 subunit (Jiang et al., 2010). The
application of thiol modifying agents, oxidants or disulfide bond oxidizing enzymes e.g., NEM,
chloramine T (CLT) disulfide or protein disulfide isomerase, does not block the effect of H2S on
the channels (Jiang et al., 2010), indicating that the modulation sites for H2S are distinct from the
sites that are modulated by thiol-modifying regents. Moreover, the study of INS-1E insulin
secreting cells found that endogenous H2S exists, which maintains the basal activity of β–cell
isoform of KATP channel (presumably Kir6.2/SUR1 channel). When the endogenously produced
H2S is diminished, exogenously applied H2S (100 µM) can further increase the KATP current
(Yang et al., 2005).
8.2 Ion channel S-glutathionylation
Since oxidative stress may lead to cysteine oxidation of a variety of proteins through
distinct modulation mechanisms, it is essential to test whether the cysteine oxidation is mediated
through disulfide bond formation, S-nitrosylation, S-glutathionylation, sulphenic (PSOH),
sulphinic (PSO2H) or sulphonic acid (PSO3H) formation using right tools. More importantly,
since different experimental conditions may cause artificial oxidation, great precautions should
be taken when studying S-glutathionylation using different oxidants. Using oxidants that are
physiologically relevant is of critical importance to demonstrate S-glutathionylation. Because not
all S-glutathionylation occurring on proteins have functional consequences, biochemical
experiments should be combined with functional experiments to provide evidence for the
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consequence of this modulation. Taken together, when testing the protein S-glutathionylation,
several things should be taken into consideration: (1) Physiological or pathological relevance of
the experimental conditions. This is important because experimental conditions are chosen to
mimic the in vivo condition. Extreme conditions may lead to drastic protein modulation which
may never occur in vivo. For example, micromolar concentrations of H2O2 are better than
millimolar concentrations of H2O2 in relation to physiological relevance. Using enzyme systems
like the XO/X system and NOX to produce endogenous ROS are also good choices. (2)
Identification of specific reactive species and modification mechanism involved. For example,
although ONOO─ is a strong endogenous RNS that have significant physiological relevance, the
application of exogenous ONOO─ is likely to cause both S-nitrosylation and S-glutathionylation
which need to be distinguished by other methods. (3) The combination of biochemical and
functional assays. Although biochemical evidence is essential, it does not reveal non-functional
S-glutathionylation. Thus, functional experiments should be combined with biochemical
experiments. (4) Identification of specific cysteine residues responsible for S-glutathionylation. It
has been shown previously that for a single protein, some of the cysteine residues tend to be Snitrosylated and others are more likely to be S-glutathionylated. Therefore, identification of the
specific cysteine residues may provide additional evidence for the understanding of how these
modulations occur. (5) Reversibility issue. S-glutathionylation is considered as reversible
reaction while some other modifications (e.g., the formation of PSO2H and PSO3H) are
considered irreversible. Using general reducing agent (e.g., DTT) or specific deglutathionylation
enzyme (Trx or Grx) to demonstrate the reversibility would aid in distinguishing Sglutathionylation from other kinds of modifications.
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8.2.1 Methods for the study of S-glutathionylation
Several methods for the study of S-glutathionylation have been developed. Sglutathionylation could occur on several proteins at multiple sites, thus, inducing Sglutathionylation and testing if this modification could affect the function of the protein of
interest is the first critical step. GSSG (1~10 mM) is often used to induce S-glutathionylation
(Chen et al., 2010; Wang et al., 2005; Yang et al., 2010) in a variety of conditions. The combined
treatments of GSH (100 uM~5 mM) with oxidants (e.g., H2O2, 100~1 mM or diamide 100~ 1
mM) are also commonly used (Yang et al., 2010; Zmijewski et al., 2009). Besides, the
application of S-nitrosoglutathione (GSNO) and ONOO─ to induce S-glutathionylation is also
often practiced (Bibert et al., 2011; Figtree et al., 2009; Townsend et al., 2009; Wang et al.,
2005). However, it is worth noting that these nitrogen species (10 ~500 µM) may lead to other
protein formations, e.g., S-nitrosylation. Thus, additional experiments should be performed to
test for S-glutathionylation when these nitrogen species are used.
In functional studies, NEM is often used to block the S-glutathionylation (Wang et al.,
2005), and reactive disulfides e.g., 5-PDS, 2-PDS, DTNB are used to resemble the addition of
glutathione moiety to the cysteine residues. These reagents, however, are also used for the study
of S-nitrosylation (Yoshida et al., 2006). The effects of reactive disulfides thus should not be
directly interpreted as the effect of S-glutathionylation. Rather, the results of the reactive
disulfide should be viewed as supportive evidence to other S-glutathionylation induction
methods.
S-glutathionylation is considered as a reversible reaction. Reducing agents, e.g., DTT
(1~20 mM) or 2-mercaptoethanol (2-ME, 1mM~10 mM), are often used to reverse the effect of
S-glutathionylation. More importantly, to be physiological relevance, S-glutathionylation should
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be reversed by specific enzymes including Grx, Trx, etc. Grx1 (1 µM-50 µM) has been
suggested to be the specific de-glutathionylation enzyme, so the Grx1-mediated recovery is often
essential to demonstrate the functional reversibility of S-glutathionylation of the protein of
interest (Wang et al., 2005; Yang et al., 2010).
Biochemical experiments are also essential evidence for the demonstration of Sglutathionylation. The most popular methods to test S-glutathionylation biochemically is to use
BioGEE

(100

µM~1

mM,

a

membrane

permeable

biotinylated

glutathione)

in

immunoprecipitation (IP, or pull-down assay) and western blot experiments (Park et al., 2009b;
Yang et al., 2010). In principle, the cells expressing proteins of interest are loaded with BioGEE
(100 µM~500 µM) first. The cells are then challenged with oxidants, e.g., H2O2 (10 µM~1 mM)
or diamide (10 µM ~1 mM) for a time period (5 min~ a few hours). After that, the cells are lyzed
and streptavidin conjugated agarose beads (or magnet beads) are used to pull down the BioGEE
conjugated protein complex. These pull-downed protein complex then will be run on nonreducing SDS gel and the protein of interest will be detected by the protein-specific antibodies
with immunoblot (IB) (Zmijewski et al., 2009). Alternatively, after the proteins are loaded with
BioGEE and challenged with oxidants, the BioGEE-protein complex could be IP first with the
specific antibodies against the protein of interest and then IB with streptavidin or anti-biotin
antibody (Townsend et al., 2009). A variation of this experiment is to avoid using BioGEE.
Instead, the cells are directly challenged with oxidants and then IP with anti-GSH followed by IB
with antibodies against the protein of interest (Anathy et al., 2009) (or vice visa, IP with specific
antibodies and IB with anti-GSH) (Figtree et al., 2009). In a few cases, the use of Biotin-GSSG
(2 mM) was reported, GSSG can directly cause S-glutathionylation so the challenge of oxidants
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may not be needed (Bedhomme et al., 2009). With many variations available, researches should
choose a method that would fit into their experimental conditions best.
Mass spectrometry (MS) is a powerful tool to detect and verify S-glutathionylation as
well (Bedhomme et al., 2009; Park et al., 2009b). GSH has a molecular weight of 305 Da (Chen
et al., 2010). If the proteins of interest are attached with GSH, the molecular weight (MW) of the
protein would show a clear shift in MS. If only one GSH is attached, then the protein MW would
be shifted by 305 Da. If two are attached, then the protein MW would shift by 710 Da (2*305)
and so on. By using MS, additional information regarding the number of GSH moieties attached
to the target protein could be obtained. Moreover, if the proteins are digested with enzymes (e.g.,
trypsin or LysC) and followed by tandem mass spectroscopy (MS/MS) analysis, the specific
cysteine sites that are S-glutathionylated could also be revealed (Bedhomme et al., 2009; Chen et
al., 2010).
In addition, systemic site-directed mutagenesis is one of the golden standards to test any
kinds of post-translational modification including S-glutathionylation (Chen et al., 2010). Single,
double, triple or even cysteine free constructs could be generated with this method. If the
proteins of interest have a homology that respond to S-glutathionylation differently, chimeras
could also be created using these two homologies to determine which domains and which motifs
are responsible for the modification. Combined with functional experiments or biochemical
experiments, the mutant proteins could provide valuable information for the molecular basis of
the modification.
The incorporated GSH moiety would interact with the surrounding amino acids and
structurally change the protein conformation thus modifying the protein function. The GSH
moiety can affect the protein structure in at least two ways: First, GSH is a tripeptide made of
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cysteine, glutamate and glycine, so its relatively big size may have steric hindrance effect on the
proteins that are normally tightly packed. Second, GSH has charged groups which may interact
with the charged groups in the protein, either attracting or repelling certain amino acids to cause
protein conformational changes. Structural modeling and molecular dynamics are useful tools to
study how S-glutathionylation affects the protein structure. To perform the analysis, the
availability of good crystallographic templates is essential. The target protein should have
conserved homologies with the crystal structure that has been determined by X-ray. If the crystal
structure is not available, the structural information provided by other methods including cryoelectron microscopy and nuclear magnetic resonance (NMR) spectroscopy may also be valuable.
Although the resolution obtained through these methods may not be high enough compared to
crystal structure, in many applications these structures are accurate enough for the study of the
interaction of attached moiety (e.g., GSH) with the target proteins.
Ion channels are membrane bound proteins which are proved to be very hard to be
crystalized. The limited availability of good templates for ion channels obscures the structural
insight of how S-glutathionylation affects the channel functions. With the recent progress in
crystal structure, studies attempting to tackle this interesting question begin to emerge. Taking
the advantage of the recently crystalized chicken Kir2.2 and the bacterial Kir channel as
templates, we model the Kir6.1 pore-forming subunit in its closed state to study how Sglutathionylation affects the KATP channel gating. With the model of Kir6.1 closed state, we
found that the target cysteine site for S-glutathionylation (Cys176) is located in the critical region
of inner helix, close to the blocking residue Phe178 (in Kir6.1) and the hinge residue Gly175 (in
Kir6.1). Phe178 is suggested to block the ion conducting pathway when the channel is in its
closed state. Gly175 is suggested to be the hinge, from where the channel bends to open. The
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Cys176 located between Phe178 and Gly175 and its side chain faces a pocket formed by inner
helix, outer helix and slide helix. When the GSH is modeled onto Cys176, we found that GSH
can fit into this pocket nicely after energy minimization. To further study how this modification
can affect the channel gating, we modeled the channel in its open state using an open state
KirBac1.1 model determined by electron crystallography (Kuo et al., 2005). The Kir6.1 channel
model in its open state shows that the inner helix undergoes a significant change, moving
laterally towards the slide helix. This movement of the inner helix disrupts the binding pocket for
GSH. Therefore, based on these models, we conclude that the incorporation of GSH moiety to
Kir6.1 subunit prevents the channel from entering its open state thus retaining the channel close.
S-glutathionylation has also been suggested to affect the ATP binding pocket of CFTR channel
(Wang et al., 2005) although detailed structural insight has not been reported presumably due to
the lack of accurate template for modeling. Our study demonstrates for the first time the effect of
S-glutathionylation on the channel gating. We expect more insight to be gained in this field with
the availability of additional channel structures.
8.2.2 S-glutathionylation of KATP channel
KATP channels are regulated by neurotransmitters and changes in the metabolic state to
regulate membrane excitability, which in turn controls insulin secretion, regulates vascular tone
and protects neurons and cardiac myocytes against hypoxia, ischemia etc. K ATP channels are
made of 4 pore-forming Kir (inward rectifier K+ channel) subunits and 4 regulatory SUR
(sulphonylurea receptors of the ATP-binding cassette) subunits. Different combinations of Kir
and SUR have been found in distinct tissues including Kir6.2/SUR1 in β-cells, Kir6.2/SUR2A in
cardiac muscle, Kir6.1/SUR2B in smooth muscles, etc. Previous studies have found that native
KATP channel can be modulated by H2O2 as well as other oxidants. In heterologous expression
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system, it is found that oxidants or thiol-modifying agents can also modulate these KATP
channels. However, whether these modulations occur in a physiologically relevant context is not
clear.
In this dissertation study, we found that the vascular KATP (Kir6.1/SUR2B) channel is
inhibited by several oxidants via S-glutathionylation of the Kir6.1 subunit. Functional studies
showed that the treatments of a variety of S-glutathionylation inducers including GSH/H2O2,
(GSH:GSSG)/H2O2, GSSG, or GSH/diamide lead to functional channel inhibition. To test the
involvements of regular disulfide bond, we studied the cells expressing Kir6.1/SUR2B channel
with diamide alone. A marked inhibition effect was not seen in this condition, which suggests
that the formation of disulfide bond between two cysteine residues may not be the reason for
channel inhibition. We further carried out biochemical experiments by treating the cells with
BioGEE together with H2O2. The proteins were lyzed from the treated cells and streptavidin was
used to pull down the BioGEE conjugated proteins. Using antibodies against Kir6.1 to probe the
pulled-down proteins, we found that glutathione was incorporated to Kir6.1 subunit of KATP
channel in oxidative stress conditions. We further performed mutagenesis analysis and identified
Cys176 as the primary S-glutathionylation site and Cys43 as a contributing S-glutathionylation
site. The Cys176 site was further confirmed by biochemical experiments. Our structural
modeling suggested that the addition of GSH moiety to Cys176, which is located in the critical
region for channel gating, creates a structural obstacle for the movement of inner transmembrane
helices and thus prevents the channel from entering its open state. Furthermore, our studies
provide evidence showing that the Kir6.2/SUR2B channel is not functionally glutathionylated
and S-glutathionylation of KATP channel is SUR2B-independent.
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Although our data suggest that cysteine-mediated posttranslational modification occur on
KATP channel, these data do not rule out other types of cysteine modulations. NO has been shown
to modulate the Kir6.2-containing channel but the underlying mechanism has been controversial
(please see ―KATP channel modulation by NO‖ for detailed description). Further research is
needed to test if S-nitrosylation and other kinds of cysteine modulation mechanisms are also
responsible for the inhibition or activation of different types of KATP channels.
8.3 ROS life-span and action range
Since most of the ROS have a limited life span, it is likely that the redox-modification
reactions occur on the proteins that are closely associated with the proteins or organelles (e.g.,
membrane bound NOX enzyme or mitochondria system) that generate ROS. Indeed, many
membrane-associated proteins or mitochondrial proteins have been found to be redox-modified.
Co-localization of the redox-modified protein TWIK-related acid-sensitive K+ channel (TASK1)
with ROS generator (NOX4) has been observed. It is not known, however, if these kinds of colocalization also exist for other proteins and ROS generators. Furthermore, if the target proteins
do have interactions with the ROS generator, then protein pull-down experiment and
Fluorescence Resonance Energy Transfer (FRET) experiment may be used to test this
hypothesis.
H2O2 has a relatively longer life span and it is suggested that H2O2 can travel in the
cytosol or across the membrane to execute its effect. However, it is also suggested that H 2O2 is a
relatively weak oxidizing agent and its cytotoxic effect is from the generation of hydroxyl
radicals through the interaction with a metal e.g., Fenton. Because of its stability and relatively
long life span, H2O2 is often chosen as the primary exogenous source of ROS to perform
experiments. However, it is worthy to keep in mind that H2O2 application in an experimental
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condition may not exactly mimic the in vivo environment and caution should be taken to
interpret the data. Therefore, using enzymatic systems or enzyme activators to manipulate the
endogenous redox system may serve as an alternative. In pathological conditions, H2O2 and
related ROS may be constantly produced. The long-lasting production of ROS may cause a
gradual inhibition of the vascular KATP channel. When the channel inhibition reaches a
significant level, a cascade of events may be triggered, leading to extensive depolarization,
excessive ROS production, structural damages to the cell, and disruption of cellular function.
Therefore, early termination of the cascade of events is necessary, which may be achieved by
activation of the KATP channels at the early stage of the pathological conditions using several
endogenous regulators such as VIP.
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